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CHAPTER 1: INTRODUCTION 
Background 
Due to widespread stigmatization of the transgender population and cultural 
assumptions about gender (Bauer et al., 2009), most healthcare providers and medical staff have 
not received adequate training to meet the unique needs of this marginalized group (Advisory 
Committee on Sexual Orientation, 2014; Sanchez, Rabatin, Sanchez, Hubbard, & Kalet, 2006). 
Consistent with trends towards patient-centered care and shared decision-making (Sheridan, 
Harris, Woolf, & Force, 2004; Stiggelbout et al., 2012), professional organizations and others 
have recently released policy and practice recommendations for providing culturally competent 
care to transgender patients (Advisory Committee on Sexual Orientation, 2014; Legal, 2014). 
Yet, very little is known about healthcare providers’ experience of providing care to transgender 
patients, their attitudes and knowledge about transgender health, their willingness to serve this 
population, or how the health system context influences physicians’ capacity to provide 
transgender-sensitive care.  
According to the National Association of Social Workers’ (NASW) Code of Ethics, 
addressing discrimination that is based on gender identity or expression is one obligation of the 
social work profession (National Association of Social Workers, 2008), and the experiences of 
bias that transgender individuals face when seeking medical attention suggest that there are 
major disparities in healthcare access and quality for this population. In one national study, 
nearly one quarter of transgender individuals reported being denied health care services 
outright, and nearly half of transgender patients who did receive care did not reveal their gender 
identity status to their healthcare providers or disclosed to only some providers due to fears of 
experiencing bias or being denied care (Grant et al., 2011). Thus, it is not surprising that 
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transgender individuals report delaying or avoiding seeking care for illnesses or injuries (Grant, 
Mottet, & Tanis, 2010) and may seek health care only for gender transition-related services 
(Jenner, 2010).  
This study used an adapted Theory of Planned Behavior to examine health care 
providers’ willingness to care for transgender individuals. Specifically, the purpose of this study 
was to examine factors associated with primary care and women’s health providers’ willingness 
to provide both routine and transition care for transgender patients. Findings from this study 
can be used to 1) identify high priority health system policy and procedural changes that are 
likely to have the greatest impact on transgender care quality;  2) design interventions for 
healthcare personnel; 3) point to implications for medical education; and 4) identify avenues 
for social work professionals to advocate for this marginalized population. 
Study Aims 
Transgender individuals face a number of barriers when accessing healthcare, and there 
are a number of gaps in the literature related to healthcare providers’ willingness to provide 
routine and transition care to this population. Thus, the aims of this study are as follows: 
1. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
and transgender care-related self-efficacy on willingness to provide routine care to 
transgender patients. 
H1: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathy attitudes, increased self-
efficacy will be positively associated with willingness to provide routine care to 
transgender individuals.  
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2. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
and transgender care-related self-efficacy on willingness to continue hormone 
therapy for transgender patients. 
H2: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathetic attitudes, increased self-
efficacy, and increased facilitators will be positively associated with willingness to 
continue hormone therapy for transgender individuals.  
3. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
and transgender care-related self-efficacy on willingness to initiate hormone 
therapy for transgender patients. 
H2: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathy attitudes, and increased self-
efficacy will be positively associated with willingness to initiate hormone therapy 
for transgender individuals.  
Significance 
This study is the first to explore factors that predict healthcare providers’ willingness to 
provide both routine and transition care to transgender individuals. By leveraging well 
established constructs that predict behavioral intentions (i.e., the Theory of Planned Behavior), 
this study is well positioned to provide unique insight into what barriers and facilitators (i.e., 
factors related to self-efficacy) limit healthcare providers’ willingness to care for transgender 
patients as well as how to alleviate those barriers. Findings from this study will inform where 
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best to intervene with medical professionals in order to improve health care quality for the 
transgender population, in terms of education, training, policies, procedures, and health system 
culture.  
Social Work Implications 
Social workers can increasingly be found providing care to patients in medical settings. 
Knowing barriers that healthcare providers may face in providing care to transgender patients 
is critical for social workers who are part of healthcare teams. Social workers are well 
positioned to advocate for vulnerable populations, and increasing evidence suggests that 
transgender persons are at risk for being denied basic health care as well as transition services, 
which may be critical for their wellbeing. Results of this study may point to the importance of 
the advocacy role that social workers can play in medical settings on behalf of vulnerable 
populations. In addition, social workers may often play a role either in providing counseling or 
therapy to transgender individuals, and they may also be in a position to assist in the 
coordination of medical transition care.  
In addition, social workers are at the forefront of developing cultural competence 
trainings, guidelines, and curricula, and are also in a position to provide training, education, and 
advocacy in medical settings. As social workers have become more involved in providing 
services in integrated healthcare settings, they will also become more involved in ensuring that 
medical care is culturally competent and equitable. The NASW Code of Ethics specifies that 
addressing discrimination due to gender identity (among other marginalized statuses) is one 
obligation of the social work profession (National Association of Social Workers, 2008). 
Nowhere is this need more critical than in the availability of basic and transition health care for 
transgender individuals.  
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CHAPTER 2: LITERATURE REVIEW 
The transgender population can be defined as those who identify conflict between their 
current gender identity and their assigned sex at birth (Kenagy, 2005). Although the transgender 
population is diverse in terms of gender identity, it may include both individuals who were 
assigned male at birth but identify as female (MTF) as well as those who were assigned female 
at birth but identify as male (FTM). The transgender population is arguably one of the most 
marginalized minority groups in the United States. In this chapter, the health care needs of the 
transgender population and healthcare discrimination experiences reported by transgender 
patients will be explored. In addition, provider-level factors, including transgender-care related 
self-efficacy, affecting care delivery to the transgender population will be described. Finally, 
gaps in the literature will be elucidated, particularly as they pertain to healthcare providers’ 
willingness to provide both routine care and medical transition care for the transgender 
population.  
Healthcare Needs of the Transgender Population 
Medical Transition Care 
Many transgender individuals either seek or would like to seek some type of transition 
care so that their physical characteristics and presentation match their gender identity 
(Davidson, 2007). Transition care may involve a number of different services, procedures, and 
medications, including hair removal, cosmetic changes, and voice coaching. Medical transition 
care generally includes counseling, cross-sex hormone treatment, and/or surgery. Several 
organizations have published guidelines to direct health and mental health providers in assisting 
patients with the transition process, including the Endocrine Society (Hembree et al., 2009) and 
the World Professional Association of Transgender Health or WPATH (Coleman et al., 2012). 
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These guidelines are based on expert opinion and give guidance on the transition process, 
including both mental health care and transition care. The transition process involves five 
progressive stages, some of which may happen concurrently, and not all transgender individuals 
complete every stage. These stages include 1) diagnosis of gender dysphoria by a licensed 
mental health professional; 2) counseling; 3) real-life experience living as one’s non-birth sex; 
4) cross-sex hormone treatment; and 5) surgery (Wilczynski & Emanuele, 2014).  
Available surgeries for transgender men and women include procedures such as facial 
feminization (for transwomen), chest surgery (breast removal or breast augmentation), 
hysterectomy (for transmen) and alteration of genitalia (metoidioplasty, scrotoplasty, 
phalloplasty, orchiectomy, and vaginoplasty) (Erickson‐Schroth, Bowers, & Carmel, 2015). 
Somewhat more accessible in terms of both cost and availability – and more commonly used 
(Grant et al., 2011) - is cross-sex hormone treatment. Hormone treatment for FTM patients 
includes testosterone injections given at regular intervals (usually every two weeks), sometimes 
with complementary androgen gel or patches. The goal of hormone treatment for FTM patients 
is essentially to induce virilization (lower voice, cessation of menses, and produce male-pattern 
hair growth) (Gooren, 2014). For transgender women, hormone treatment includes the use of 
either oral or transdermal estrogen, with the goal of changing body fat distribution, reducing 
hair growth, and feminizing body shape (i.e., breast augmentation) (Wierckx et al., 2012). 
Cross-sex hormone treatment may be particularly important for transgender individuals, 
as multiple studies have identified positive mental health effects of such treatment. One 
longitudinal study found significant improvements in depression, anxiety, psychological 
symptoms, and functional impairment at one year after the onset of cross-sex hormone 
treatment for transgender individuals (Colizzi, Costa, & Todarello, 2014). Another study of 
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transwomen in San Francisco found that use of transition-related medical care (hormone 
treatment) was associated with lower risk of binge drinking, drug use, and suicidal ideation, 
suggesting that transition care may reduce mental health and behavioral risks among this 
population (Wilson, Chen, Arayasirikul, Wenzel, & Raymond, 2015). The same is true of 
samples of transmen; a prospective study found that three months of hormone treatment was 
associated with better quality of life and mental health compared to a control group (Keo-Meier 
et al., 2015). The documented positive effects of hormone therapy for transitioning individuals 
points to the importance of the availability of this type of care. 
A number of medical professionals are involved in the transition process, but “family 
and internal medicine physicians continue to deliver the care in the long term” (Wilczynski & 
Emanuele, 2014, p. 121). Hormone therapy is both beneficial and straightforward and can be 
provided by primary care physicians and as well as other providers (Gardner & Safer, 2013). 
For example, patients being treated with hormones require routine lab monitoring to ensure 
optimal hormone levels as well as annual renal and liver function tests, among others, to 
determine whether adverse effects require changes in hormone regimens – all of which is 
routinely ordered by primary care providers (Wilczynski & Emanuele, 2014). 
Routine Care 
In addition to transition care, transgender individuals require basic routine medical 
care for illnesses or injuries, for the treatment of chronic diseases such as diabetes or cancer, 
as well as preventive care such as cancer screenings and blood pressure monitoring. However, 
hormone use, surgeries, and other medical transition steps may affect their healthcare needs in 
a way that is unique. For example, because Prostate Specific Antigen (PSA) levels are low 
when testosterone levels are low, a PSA test is not an appropriate screening mechanism for 
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prostate cancer for transwomen on transition hormone regimens – digital rectal exams are 
recommended instead (Center of Excellence for Transgender Health, 2011). In addition, 
testosterone use may increase the incidence of polycystic ovarian syndrome among transmen 
(Moore, Wisniewski, & Dobs, 2003). In turn, chronic disease and other health-related factors 
may affect recommended hormone protocols or dosages. For example, more frequent and 
lower testosterone doses are recommended for transmen with histories of trauma, as high or 
frequent doses may cause emotional distress (Center of Excellence for Transgender Health, 
2011). 
Health and Mental Health Disparities 
The transgender population also experiences a number of health disparities which 
increases the need for access to appropriate routine and transition care. Although there is a lack 
of population-level data on the health of the transgender population, existing evidence points to 
both behavioral and mental health disparities. In particular, transgender young adults are more 
likely to report heavy episodic drinking compared to non-trans young adults (Coulter et al., 
2015). Transmen and women also report a high prevalence of using alcohol and other drugs to 
cope with experiences of stigma (Grant et al., 2011). The rate of smoking is also higher among 
the transgender community than both lesbian, gay, or bisexual (LGB) individuals and the 
general population (Shires & Jaffee, 2015b). Due to job discrimination and a resultant frequent 
incidence of sex work, particularly among MTF, transgender individuals are at high risk for 
HIV and other STIs. Depression is also common and the rate of suicidality and suicide attempts 
among transgender persons are astronomically high (Grant et al., 2011; Kenagy, 2005). The 
screening, diagnosis, and potential referrals that so often occur in primary care settings may be 
crucial for transgender individuals who are smokers or have mental health or substance abuse 
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issues. Likewise, as stated above, there is an established link between hormone use and mental 
health status, so access to hormones may also contribute to alleviating mental health concerns 
and risk behaviors (Colizzi et al., 2014; Keo-Meier et al., 2015; Wilson et al., 2015).  
Healthcare Experiences Reported by Transgender Patients 
An emerging body of literature suggests that transgender patients often have negative 
experiences when seeking health care services, which may contribute to not being able to access 
appropriate routine or transition care. One study recently found that 25% of transgender 
participants in a survey in Virginia were not able to access needed trans-specific healthcare 
services in the past 12 months. Of these, 31% of those could not access hormone therapy, 25% 
could not access surgery, 25% could not access counseling, and 19% could not access 
gynecological care (Bradford, Reisner, Honnold, & Xavier, 2013). Previous studies, 
summarized below, have highlighted transgender patients’ perceptions that their providers 
generally do not know how to appropriately treat them, documented incidents of harassment 
and violence, and examined the prevalence of denial of care to this population.  
Providers’ Lack of Knowledge 
A number of qualitative studies have found that transgender patients report that their 
physicians appear to be at a loss at how to provide care to them (Bauer et al., 2009; Poteat, 
German, & Kerrigan, 2013a). Poteat and colleagues (2013a) found that transgender patients felt 
that providers would not meet their needs or even be prepared to treat them at all. When 
transgender patients have more information about their healthcare needs than the providers who 
are treating them, the resulting shift in power can make providers quite uncomfortable and result 
in substandard care for patients (Poteat et al., 2013a). Alternatively, a lack of knowledge on the 
part of providers may directly result in care that is not ideal. 
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More recent quantitative studies have confirmed these findings. Research using data 
from the landmark National Transgender Discrimination Survey (Grant et al., 2011) suggest 
that over half of transgender participants have to teach their healthcare providers about 
transgender health issues (Jaffee, Shires, & Stroumsa, in press). In a sample of transgender 
individuals in Virginia, 20% of the respondents reported having to educate their providers about 
transgender health issues (Bradford et al., 2013). A recent study of transgender individuals in 
Ontario, Canada found that many transgender patients (31% of transmen and 41% of 
transwomen) reported that their primary care provider was not at all knowledgeable about 
transgender issues (Bauer, Zong, Scheim, Hammond, & Thind, 2015). Collectively, these 
studies indicate that having to teach a provider about transgender health is a relatively common 
experience among transgender individuals seeking care. 
Harassment and Discomfort 
Numerous studies have documented experiences of bias against transpeople in 
healthcare settings, and some transgender people even reported being physical assaulted when 
seeking care (Grant et al., 2010; Shires & Jaffee, 2015a). Qualitative studies provide insights 
into these experiences; transgender patients have reported being ridiculed or harassed by front 
desk or pharmacy staff (Hussey, 2006), having their genitals or gender presentation be a focus 
of the consultation even when irrelevant (Sperber, Landers, & Lawrence, 2005), and having 
mental health issues blamed on their transgender identity (Bauer et al., 2009). They have also 
reported having their provider refuse to use their preferred pronoun (Hussey, 2006; Sperber et 
al., 2005), or feeling like their very existence as a transperson was being questioned (Bauer et 
al., 2009; Poteat et al., 2013a). 
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Denial of Care 
Prior studies have also found that transgender individuals are often refused care outright. 
In a 2005 needs assessment of transgender persons in Chicago, 12% had been refused routine 
care and 23% had been refused transition-related care; 38% of respondents said that being 
transgender created a problem for them related to seeking an annual physical (Kenagy & 
Bostwick, 2005). A quarter of participants in the National Transgender Discrimination Survey 
(NTDS) reported being refused care in a doctor’s office or hospital (Grant et al., 2011), although 
whether participants were referring to routine care or transition care is unclear. In one study, 
25% of transmen and 29% of transwomen had been told by a family or primary care physician 
in the past that they don’t know enough about trans-related care to provide it, and 7% and 5%, 
respectively, were denied care by a family physician because they are transgender (Bauer et al., 
2015). Qualitative studies have documented similar issues (Bauer et al., 2009; Poteat et al., 
2013a). 
Implications of Reported Healthcare Experiences 
Ultimately, negative experiences with physicians and other healthcare providers may 
prevent transgender patients from seeking and obtaining needed routine and transition care. In 
a Virginia study, only 43% of respondents reported being “out” to their primary care provider, 
and 15% were uncomfortable or very uncomfortable discussing trans-specific healthcare needs 
with their primary care provider (Bradford et al., 2013). Bauer and colleagues (2015) found that 
when sociodemographic and trans-specific factors were controlled, prior negative experiences 
and perceived lack of provider knowledge predicted discomfort with discussing trans-related 
issues with a family physician. In addition, unadjusted analyses indicated that transgender 
individuals who were planning to transition were more likely to report discomfort. Transgender 
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participants in the NTDS who had to teach their providers about transgender health were four 
times more likely than others to delay or avoid needed medical care (Jaffee, Shires, & Stroumsa, 
in press). Finding appropriate healthcare can be an arduous task for many transgender persons 
and may involve extensive research, travel, persistence, and finding insurance and policy 
loopholes (Roller, Sedlak, & Draucker, 2015). In short, prior studies indicate that the barriers 
reported by transgender individuals in need of care are nearly ubiquitous and extremely 
daunting.  
Provider-Level Factors Affecting Care Access for Transgender Patients 
Although barriers to care from the perspective of transgender people have been 
documented, less well understood is the perspective of healthcare providers and factors that 
may contribute to difficulty in providing sensitive and high quality care to the transgender 
population. This section reviews the available literature in this area, particularly as it pertains 
to provider empathy, attitudes, subjective norms, exposure to transgender individuals, and 
willingness to care for this population. Subsequently, gaps in the literature, both methodological 
and content-related, will be described.  
Exposure to Transgender Individuals 
Studies of adolescent medicine and HIV providers indicate a fairly high level of 
experience with transgender patients among this provider population. Among members of the 
Society for Adolescent Health and Medicine and the Pediatric Endocrine Society, a majority 
(67%) had provided clinical care to transgender youth; respondents had previously treated a 
mean of 10.4 adolescent transgender patients each (Vance, Halpern-Felsher, & Rosenthal, 
2015). Among HIV providers in New England, participants in a qualitative study reported 
having a broad range of experience with transgender patients (Lurie, 2005). However, these 
13 
 
providers likely do not represent primary care providers or clinicians generally, and no studies 
to date have measured exposure to transgender patients among family medicine, internal 
medicine, or ob-gyn providers in general.  
Although the link between exposure to transgender individuals and willingness to 
provide care to this population has not been studied, studies of clinicians’ attitudes towards 
other vulnerable patient groups indicate a relationship between comfort or willingness to treat 
and either personal or professional experience with this group. In a study of nursing students, 
exposure (either personal or clinical) was positively correlated with comfort level in working 
with patients of diverse races, gay, lesbian, or bisexual individuals, terminally ill patients, and 
HIV positive patients, among others (Eliason & Raheim, 2000). Another study found that 
exposure to gay and lesbian physicians and hearing their stories had an impact on decreasing 
homophobia among medical students (Wallick, Cambre, & Townsend, 1995). 
Empathy for Transgender Patients 
Empathy, or the ability to understand another person’s feelings or point of view, is seen 
as particularly important to the practice of medicine (Larson & Yao, 2005; Spiro, 2009). Prior 
studies have linked physician empathy not only to patient satisfaction (Sullivan, Stein, 
Savetsky, & Samet, 2000) but to clinical outcomes and factors that influence clinical outcomes, 
including compliance (S. S. Kim, Kaplowitz, & Johnston, 2004). In one study, patients with 
diabetes who perceive that their providers have greater levels of empathy had significantly 
better clinical control of both their LDL cholesterol and hemoglobin A1C (Hojat et al., 2011). 
Among medical students, empathy was positively associated with better core clinical skills 
(Hojat, Gonnella, Mangione, et al., 2002). Although there is general agreement that empathy 
can be taught, there is some evidence that female physicians have higher levels of empathy 
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compared to male physicians, particularly in the area of “perspective taking” (Hojat, Gonnella, 
Nasca, et al., 2002). 
No studies to date have specifically examined the impact of provider empathy on 
willingness to care for marginalized populations such as the transgender community, but at least 
one qualitative study points to empathy as a potentially important factor: “Where providers sat 
on the continuum between participation and resistance to transgender stigma/discrimination 
seemed to be a function of empathy. Lesbian and gay providers as well as other providers who 
felt a personal connection to transgender people were more likely to express resistance to 
stigmatization of transgender people” (Poteat et al., 2013a, p. 27). 
Perceived Knowledge about Transgender Health 
One of the biggest barriers to treating transgender patients reported by healthcare 
providers is feeling that they do not have the appropriate training or knowledge. Several prior 
qualitative studies found that providers who serve transgender patients report feeling 
uncomfortable or ambivalent about treating this population due to a lack of skills, training, and 
information in this area (Lurie, 2005; Poteat, German, & Kerrigan, 2013b). Quantitative studies 
report similar findings. Among a national sample of adolescent health care providers, most 
participants (75%) were familiar with the Endocrine Society’s guidelines around transgender 
medical therapy (Vance et al., 2015), but only 18% agreed that their training had adequate 
emphasis on transgender care. Most had learned about caring for transgender youth after 
medical school, and the majority wanted to learn more about caring for transgender youth (86%) 
(Vance et al., 2015).  
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Willingness to Provide Care 
Based on reports of transgender patients, healthcare institutions generally have a long 
way to go in order to ensure that care provided to the transgender community is sensitive and 
culturally appropriate. The first step to alleviating these disparities, however, is to assess 
whether providers are even willing to care for this population. Since transgender patients often 
report being denied care, this is an extremely salient line of inquiry. Very few studies to date 
have examined healthcare providers’ willingness to treat transgender patients. Unger (2015) 
surveyed obstetrician-gynecologists in nine healthcare institutions across the United States, 
with a resulting sample size of N=141. Providers were asked about both routine and transition 
care services for transgender patients. In terms of routine care, a vast majority of respondents 
(90%) reported being willing to provide routine pap smears for FTM patients who had not 
undergone hysterectomy; 80% agreed that they would be willing to perform breast 
examinations for MTF patients using estrogen. When asked about transition care, 65% were 
willing to perform hysterectomies for FTM patients who had met the criteria for surgical 
transition. Despite this willingness, only 29% and 34% of respondents reported that they were 
comfortable caring for FTM and MTF patients, respectively. Although this study provides some 
insight into willingness to care for transgender patients among obstetrician-gynecologists, it 
does not address either other types of primary care providers or factors associated with 
willingness to care for transgender patients.  
Justification for the Current Study 
There is increasing evidence that health outcomes for transgender patients are 
suboptimal, and a lack of access to appropriate and sensitive care is a major barrier to improving 
health among this population. It is critically important for transgender patients to receive both 
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necessary routine care as well as desired transition care, and existing evidence suggests that 
transgender patients are denied both routine and transition care on a regular basis. However, 
little is known about what factors predict healthcare providers’ willingness to provide both 
routine care and transition care to transgender patients. Barriers such as lack of knowledge or 
training about transgender health clearly play a role, but it appears that motivated providers are 
able to overcome such barriers (Vance et al., 2015).  
In terms of transition care, primary care providers – such as internal medicine, family 
medicine, and ob-gyn providers - are best positioned to either initiate or continue hormone 
therapy for the transgender population. Prescribing hormones and monitoring hormonal 
imbalances is well within the purview of primary care providers, for instance, in the case of 
polycystic ovarian syndrome (Shannon & Wang, 2012) or hormone replacement related to 
menopause (De Villiers et al., 2013). The only study assessing primary care providers’ 
willingness to treat transgender patients (Unger, 2015) did not assess willingness to provide 
hormone treatment (either initiating or continuing hormone care). This question represents a 
sizable gap in the literature, as the responsibility of managing gender-transition hormonal 
regimens can and should fall to primary care providers (Wilczynski & Emanuele, 2014). 
Whether a provider is willing to provide care to transmen and women or not is likely a 
complex interplay between the providers’ personal characteristics, exposure to transgender 
patients, empathy towards this population, attitudes regarding gender norms, and self-efficacy 
around providing such care (including perceived knowledge). The results of this study may 
point to potential improvements in medical and nursing education, healthcare organizations’ 
policies and procedures, or other target areas that will improve transgender health care. 
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Identifying key factors related to providers’ willingness to care for this population is critical to 
learn where to most effectively intervene to improve transgender healthcare.  
Theoretical Framework 
The theoretical framework for this study was primarily informed by the Theory of 
Planned Behavior (Ajzen, 1991), but it was also influenced by Intergroup Contact Theory 
(Pettigrew, 1998). The Theory of Planned Behavior, an adaptation of the Theory of Reasoned 
Action (Madden, Ellen, & Ajzen, 1992), posits that three main factors influence behavioral 
intentions, and thus, behaviors: attitudes toward the behavior, subjective norms related to the 
behavior, and perceived behavioral control. The Theory of Planned Behavior (TPB) has 
previously been used to predict the behavior of physicians and other healthcare providers. For 
example, these constructs have successfully predicted whether physicians will deliver 
counseling regarding the prevention of sexually transmitted infections to adolescent patients 
(Millstein, 1996). The TPB has also been used to predict whether pharmacists will participate 
in a drug monitoring program for their patients (Gavaza, Fleming, & Barner, 2014).  
To date, the TPB has not been used to assess whether healthcare providers are willing 
to treat a marginalized patient population such as the transgender community. Like the rest of 
the population, healthcare providers are vulnerable to social biases and prejudice. Thus, it is 
critical to account for potential bias, or factors that may mitigate bias, in the theoretical 
framework for this study. Intergroup Contact Theory predicts that, through a number of 
mechanisms, individuals who have contact with a member of an “out-group” will have more 
positive attitudes towards that group (Pettigrew, 1998).  
The modified TPB used in this study contains elements of both of these theories (as 
illustrated in Figure 1). I predict that increased personal and clinical exposure to transgender 
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individuals, fewer negative attitudes regarding non-binary gender norms (transphobia), 
increased empathy towards transgender patients (empathetic attitudes), and greater self-efficacy 
(fewer reported barriers and more reported facilitators) related to treating transgender patients 
will predict providers’ increased willingness to provide routine care, continue HT, and initiate 
HT for transgender patients. 
  
Figure 1. Theoretical framework: Modified theory of planned behavior. 
Study Aims 
Given the range of barriers faced by transgender individuals when accessing healthcare 
and known gaps in the literature related to healthcare providers’ willingness to provide routine 
and transition care to transgender patients, the aims of this study are as follows: 
4. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
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and transgender care-related self-efficacy on willingness to provide routine care to 
transgender patients. 
H1: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathy attitudes, increased self-
efficacy will be positively associated with willingness to provide routine care to 
transgender individuals.  
5. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
and transgender care-related self-efficacy on willingness to continue hormone 
therapy for transgender patients. 
H2: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathetic attitudes, increased self-
efficacy, and increased facilitators will be positively associated with willingness to 
continue hormone therapy for transgender individuals.  
6. To determine the association between provider characteristics, personal and 
clinical exposure, transphobia, empathetic attitudes towards transgender patients, 
and transgender care-related self-efficacy on willingness to initiate hormone 
therapy for transgender patients. 
H2: When provider characteristics are controlled, increased personal and clinical 
exposure, decreased transphobia, increased empathy attitudes, and increased self-
efficacy will be positively associated with willingness to initiate hormone therapy 
for transgender individuals.  
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CHAPTER 3: METHODOLOGY 
This study is an analysis of de-identified survey data that were used to measure factors 
associated with primary care providers’ willingness to treat transgender patients at Henry Ford 
Health System. All study procedures and materials were approved by Henry Ford’s Institutional 
Review Board. The study population, setting, participants, sampling, survey instrument, 
analytical variables, and analysis, and data screening process are described below.  
Study Population 
Setting 
Henry Ford Health System is an integrated care delivery system serving Detroit, 
Michigan and its surrounding suburbs. The system owns a medical group of over 1,000 salaried 
physicians and staffs 26 primary care clinics throughout metropolitan Detroit. The health 
system has taken a number of steps to promote sensitivity to lesbian, gay, bisexual, and 
transgender patients and employees. For example, the system added sexual orientation to its 
employee and patient non-discrimination policies, though to date, gender identity has not been 
included in system non-discrimination policies. Various diversity initiatives have begun to 
address sexual orientation and gender identity in the health system, and the Health System was 
designated as a LGBT healthcare equality leader in 2014 by the Human Rights Campaign. An 
internal group has developed and piloted a LGBT sensitivity training for health system 
providers and staff. Additionally, in the Fall 2015, the Human Resources department began 
developing a plan to make the system more sensitive to transgender employees. However, 
gender identity and sexual orientation information is not routinely collected from patients. 
Despite strides in inclusivity, many improvements are still needed.  
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Sampling 
Eligible participants included all primary care (internal medicine and family medicine) 
and women’s health providers practicing in the health systems’ affiliated medical group, 
including attending physicians, advanced practitioners (physician assistants, nurse 
practitioners, and certified nurse midwives), and medical residents. Health system and 
departmental records were used to identify the study sample and to acquire each eligible 
participant’s name, degree, specialty, and email address. In order to maximize sample size, the 
universe of eligible participants was included in the sampling frame (N=389). The final sample 
included 223 respondents, for an overall response rate of 57% (range = 45% to 100%, 
depending on provider type and specialty). Table 1 describes the response rate overall, by 
specialty, and by provider type. 
Table 1 
 
Provider Survey Response Rates 
Provider specialty/type 
Eligible 
(n) 
Respondent 
(n) 
Response rate 
(%) 
    
Internal medicine    
Physicians 97 44 45 
Advanced practitioners 5 3 60 
Residents 117 66 56 
    
Family medicine    
Physicians 64 32 50 
Advanced practitioners 1 1 100 
Residents 24 17 71 
    
Women’s health    
Physicians 43 30 70 
Advanced practitioners 23 19 83 
Residents 15 11 73 
    
    
Total 389 223 57 
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Data Collection 
Procedures  
The survey was programmed into an online data collection tool. Study data were 
collected and managed using REDCap (Research Electronic Data Capture) electronic data 
capture tools hosted at Henry Ford Health System. REDCap is a secure, web-based application 
designed to support data capture for research studies, providing 1) an intuitive interface for 
validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) 
automated export procedures for seamless data downloads to common statistical packages; and 
4) procedures for importing data from external sources (Harris et al., 2009). A unique link to 
the survey was sent to each eligible participant in an email that contained informed consent 
information, including an assurance of confidentiality and the voluntary nature of the survey, 
along with information about the study incentives. Two follow-up emails were sent to non-
respondents. The survey took approximately 15 minutes to complete. Data were collected in 
November and December of 2015; the survey link was emailed to eligible participants on 
November 3, 2015. A reminder email was sent to remaining non-respondents on November 10, 
2015, and a second reminder was sent to non-respondents on November 18, 2015. The online 
survey was closed on December 18, 2015.  
Incentives 
Participants were each offered a $30 gift card to Target, a chain retail store. In addition, 
participants were automatically entered into a random draw to be chosen to receive one of three 
$100 Target gift cards. Incentives were mailed to participants within three weeks of survey 
completion along with a letter thanking them for participating in the study that was signed by 
the Principal Investigators (Deirdre Shires and Daphna Stroumsa).  
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Measurement 
Survey Instrument  
The survey was developed in part based on adaptations of previously published survey 
questions or previous studies whose authors were willing to share survey instruments; some 
questions were developed specifically for this study. The relevant domains addressed in the 
survey include provider demographics (constructed for this study), personal exposure to 
transgender individuals (Berkman & Zinberg, 1997), clinical exposure to transgender patients 
(construct for this study), willingness to care for transgender patients (Kelley, Chou, Dibble, & 
Robertson, 2008; Unger, 2015), attitudes about gender norms (Nagoshi et al., 2008), and 
provider empathy (Kiersma, Chen, Yehle, & Plake, 2013). The survey instrument is included 
in Appendix A. Table 2 describes each of the theoretical constructs, corresponding survey 
domains, and corresponding question numbers.  
Control Variables 
Provider characteristics included age, gender, specialty, provider type, gender, 
race/ethnicity, religious identity, religiosity, and political views. Age was analyzed as a 
continuous variable (i.e., age in years). Provider type included resident/fellow, advanced 
practitioner, or attending physician. Specialty was categorized as internal medicine, family 
medicine, general women’s health, or women’s health specialty. Gender was categorized as 
male or female. Race/Ethnicity was categorized as African American, White, Asian or Pacific 
Islander, or Other. Religion was categorized as Atheist/Agnostic, Christian, Muslim, Jewish, 
Hindu, and Other. Religiosity was categorized as not religious, slightly religious, moderately 
religious, and very religious. Political views were categorized as liberal, moderate, or 
conservative. 
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Table 2 
 
Survey Domains Related to Theoretical Constructs 
Study construct Domains/questions 
Question 
numbers 
   
Personal exposure  Ever met transgender person 
 Has transgender acquaintances/colleagues 
 Hast transgender friends/family 
13-15 
   
Clinical exposure  Cared for transgender patient in past 5 years 
 Ever continued hormone therapy 
 Ever initiated hormone therapy 
17-19 
   
Empathetic attitudes  Empathy towards transgender patients 40-43 
   
Transphobia  Opinions regarding binary gender categories 
and cultural gender norms 
44-51 
   
Self-efficacy  Familiarity with routine care and transition 
care protocols for trans patients 
 Barriers to treating trans patients, related to 
knowledge, insurance, staff, etc. 
20; 25-26 
 
32-38 
   
Willingness  Willingness to provide routine care  
 Willingness to continue hormone therapy 
 Willingness to initiate hormone therapy 
21-24 
27 
28-29 
    
 
Independent Variables 
The construction of independent variables was driven by the Theory of Planned 
Behavior and Intergroup Contact Theory (as described above) and included personal exposure, 
clinical exposure, empathetic attitudes towards transgender individuals, transphobia, self-
efficacy, and willingness to care for transgender patients. The variables included in each of 
these domains are described below along with their sources, including three scales: transphobia, 
empathy, and knowledge barriers. For each scale, exploratory factor analysis was conducted in 
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order to examine factor structure. Cronbach’s alpha was also examined to determine whether 
each scale demonstrated internal consistency.  
Personal Exposure 
Personal exposure was measured using three binary variables, ever met a transgender 
person (constructed from 2 questions assessing whether the participant had met a female-to-
male transgender person or met a male-to-female transgender person), transgender 
acquaintances or colleagues, and transgender friends or family. Personal exposure questions 
were constructed for this study but loosely based on a previously published study about social 
workers’ attitudes towards gay and lesbian individuals (Berkman & Zinberg, 1997). 
Clinical Exposure 
Clinical exposure to transgender patients was characterized by three binary variables, 
cared for transgender patient in past 5 years (yes/no); ever continued hormone therapy (HT) for 
transgender patient (yes/no), and ever initiated HT for transgender patient (yes/no). Clinical 
exposure questions were constructed for this study. 
Empathetic Attitudes 
A brief empathy scale was constructed to characterize attitudes towards transgender 
patients. Due to space limitations, four questions were taken from a previously validated 15-
item empathy scale tested with healthcare providers, with permission from the original authors 
(Kiersma et al., 2013). Two of the selected questions addressed cognitive empathy and two 
questions addressed emotional empathy. The questions used a 7-point Likert scale, where 
responses ranged from “strongly disagree” to “strongly agree”. One question (#41 on the 
survey) was subsequently dropped due to a lack of correlation with the other three questions 
and questionable face validity.  
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To calculate the scale, the item answers were summed and a mean of the summed items 
was calculated. Item means ranged from 5.4 – 6.2 (on a 7 point scale), indicating that on 
average, participants somewhat agreed or agreed with empathy statements (higher scores 
indicate higher levels of empathy). Factor loadings for the scale ranged from .431 - .849 on one 
factor and Cronbach’s alpha was low (.320). However, the scaled variable was used due to the 
consistent relationships between each of the 3 individual items and the outcome variables.  
Transphobia 
In order to measure transphobia, a previously published scale of attitudes regarding 
gender non-conformity was used, with items measured on a 7-point Likert scale where answers 
ranged from “strongly disagree” to “strongly agree” (Nagoshi et al., 2008). Eight of the nine 
original questions were used for this study; question #1 from the original scale was dropped 
due to lack of relevance to the current study. To calculate the scale, the item answers were 
summed and a mean of the summed items was calculated. Higher scores indicated a greater 
degree of transphobia. Exploratory factor analysis indicated that all 8 items loaded onto one 
factor; factor loadings ranged from .510 - .814. Cronbach’s alpha for the resulting scale was 
.846.  
Self-efficacy 
A scale (knowledge barriers) was constructed using four questions regarding 
knowledge-related barriers to treating transgender patients due to the consistent relationship 
between these variables and the study outcomes. Knowledge barriers included barriers related 
to training on transgender health issues and familiarity with gender transition guidelines. Each 
barrier where there was agreement (somewhat agree, agree, or strongly agree) constituted 1 
point on the barriers scale (potential range = 0-4). This scale demonstrated good internal 
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consistency (Cronbach’s alpha = .849), with item means ranging from .393 - .578. All four 
items loaded onto one factor, with factor loadings ranging from .790 - .886.  
Two other barriers were dichotomized, both related to administrative issues: don’t know 
how to bill for services for transgender patients and lack of insurance reimbursement. Other 
self-efficacy variables included feeling capable of providing routine care and being familiar 
with any hormone regimen. These questions were adapted from another study with the author’s 
permission (Unger, 2015).  
Willingness  
Three domains were measured here, including willingness to provide routine care, 
willingness to continue HT, and willingness to initiate HT. These were measured on a 7-point 
Likert scale with answers ranging from “strongly agree” to “strongly disagree”. Binary (yes/no) 
outcome variables were constructed for each of these continuous variables, where participants 
indicating that they “strongly agree”, “agree”, or “somewhat agree” were coded “yes”. All 
others were coded “no”. Willingness questions were adapted from another study with the 
author’s permission (Unger, 2015). 
Data Screening 
Data screening was conducted in order to 1) assess missing data patterns; 2) detect 
potential collinearity among predictor variables; and 3) assess normality of data.  
Missing Data 
Each of the analytical study variables was examined for missing data. Table 3 below 
indicates the level of missing data for each variable of interest. Each analytical variable was 
complete for 90% or more of the study sample. Most variables had missing data for less than 
five percent of respondents; only two variables (constructed scales) were missing for 5-10% of 
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participants. Participants with missing data were excluded listwise for descriptive analyses and 
pairwise for bivariate analyses. Only participants with full data for each variable of interest 
were included in multivariate models. 
Table 3 
 
Frequency of Missing Data for Analytical Study Variables 
Percent of participants with 
missing responses Variables 
  
<1% Age, sex, religion, religiosity, political views, ever met a 
transgender person, have transgender acquaintance or 
colleague, have transgender friends or family 
 
  
1% to <5% Sexual orientation, empathy scale, familiar with hormone 
therapy regimen, insurance barrier, billing barrier, willing 
to initiate hormone therapy, willing to provide routine care, 
willing to continue hormone therapy 
 
  
5% to <10% Transphobia scale, knowledge barriers scale 
  
 
Normality of Continuous and Ordinal Variables 
Tests for normality were conducted for both ordinal and continuous variables. 
Specifically, skewness and kurtosis were examined as well as histograms of each variable’s 
distribution. The Kolmogorov-Smirnov Test for normality, which is appropriate for large 
sample sizes, was also conducted for each ordinal and continuous variable (Mertler & Vannatta, 
2002).  
Table 4 describes the psychometric properties of each of the continuous and ordinal 
study variables, including an assessment of the possible and actual range, the skewness and 
kurtosis, and whether or not the Kolmogorov-Smirnov test for normality was statistically 
significant. Overall, the only major indicator of non-normality was a significant Kolmogorov-
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Smirnov test for each study variable; however, this test is very sensitive and should generally 
be interpreted in light of other measures of normality (Mertler & Vannatta, 2002). None of the 
analytical variables were severely positively or negatively skewed (i.e., >1.00 or < -1.00) 
(Mertler & Vannatta, 2002). 
When individual variables are examined, age showed a slight positive skew, with a 
number of participants clustered around the younger age range (i.e., 26-33 years old). 
Transphobia scale results also showed a positive skew, indicating that participants cluster 
around the lower end of the scale (i.e., less transphobia). Finally, empathy scale results were 
somewhat negatively skewed, indicating that a number of participants reported higher levels of 
empathy.  
Table 4 
 
Psychometric Properties of Continuous and Ordinal Study Variables 
Variable N M (SD) 
Possible 
range 
Actual 
range Skewness Kurtosis 
K-S Test  
p value 
        
Age 222 41.3 
(13.6) 
— 26–72 .526 -1.204 <.001 
Political views 223 1.7 (0.7) 1–3 1–3 .543 -1.015 <.001 
Empathy scale 214 5.8 (0.9) 1–7 3.3–7 -.533 -0.247 <.001 
Transphobia scale 201 3.09 (1.1) 1–7 1–7 .628 0.583 .038 
Knowledge 
barriers scale 
211 1.9 (1.6) 0–4 0–4 .054 -1.606 <.001 
        
 
Multicollinearity Assessment  
Two steps were taken in order to detect potential collinearity among raw variables: 1) a 
variance inflation factor (VIF) was calculated for all independent variables; and 2) Pearson’s r 
tests were conducted for certain variables of interest. Pearson’s r carries assumptions of data 
normality (Hauke & Kossowski, 2011), but each of the continuous and ordinal study variables 
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exhibited signs of normality so Pearson’s r is an appropriate test (see Table 5). An analysis of 
VIF for each independent variable showed no signs of multicollinearity; VIF ranged from 1.122 
to 1.987, well within the normal range (1-10). Bivariate correlations were also assessed between 
empathetic attitudes, transphobia, political views, and religiosity.  
Table 5 
 
Correlations Between Clinical and Personal Exposure Variables 
Variables 
Ever 
met 
Acq or 
Col 
Friend 
or Fam 
Past 5 
years 
Initiate 
HT 
Contin 
HT 
       
Ever met transgender 
person 
— .19 .05 .49 .08 .21 
Transgender Acquaintance 
or colleague 
 — .30 .11 .02 -.05 
Transgender Friends or 
family 
  — .11 .12 .06 
Transgender patient in past 
5 years 
   — .15 .29 
Ever initiated HT     — .21 
Ever continued HT      — 
       
 
Table 6 
 
Correlations Between Self-efficacy Variables 
Variables 
Capable 
Routine 
Familiar 
HT 
Insurance 
Barrier 
Billing 
Barrier 
Know 
Barriers 
      
Capable of providing 
routine care 
— .16 .03 -.05 -.34 
Familiar with HT 
regimen 
 — .16 .02 -.21 
Insurance barrier   — .32 .21 
Billing barrier    — .30 
Knowledge barriers 
scale 
    — 
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Table 7 
 
Correlations Between Transphobia, Religiosity, Political Views, and Empathy 
Variables Transphobia Religiosity 
Political 
views 
Empathy 
Scale 
     
Transphobia — .21 .45 -.46 
Religiosity  — .30 -.10 
Political views   — -.24 
Empathy scale    — 
     
 
A number of significant correlations between study variables were detected. The highest 
correlation between exposure variables was between ever met a transgender person and cared 
for a transgender patient in the past 5 years (r=.49; Table 5). Among self-efficacy variables, 
feeling capable of providing routine care and the knowledge barriers scale were the most highly 
correlated (r= -.34; Table 6). Finally, the correlation between political views and transphobia 
(.45) and the correlation between empathetic attitudes and transphobia (-.46) were also 
relatively high (Table 7). However, no multicollinearity issues were detected, as correlations 
among variables were all <.80. 
Statistical Analysis 
Univariate Analysis 
Descriptive analyses were conducted for all study variables, including frequencies for 
nominal measures and means and standard deviations for ordinal and continuous measures.  
Bivariate Analysis 
Chi square tests and t-tests for nominal and continuous variables, respectively, were 
conducted to assess the relationship between each predictor variable and the dichotomous or 
categorical study outcomes.  
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Multivariate Analysis  
Due to the nature of primary care practice (providers practicing within certain clinics or 
sites), conducting multilevel analyses would be preferable. However, in order to perform 
multilevel analyses such as HLM or the mixed model procedure in SPSS, an adequate number 
of respondents per group is needed; one recommended benchmark is 30 respondents each 
within 30 groups (Hofmann, 1997), although a greater number of groups can compensate for a 
smaller number of respondents per group and vice versa. Because the total sample size is N=223 
respondents nested within 24 sites, there is not enough power to conduct multilevel modeling. 
In addition, medical residents and other providers practice in multiple sites, including providing 
inpatient care, making nesting providers within sites extremely difficult.  
Thus, binary logistic regression was chosen for the multivariate analysis in this study. 
Three logistic regression models were examined, one to predict willingness to provide routine 
care, one to predict willingness to continue HT, and one to predict willingness to initiate HT. 
Variables were entered simultaneously.  
A ratio of at least 10 events per predictor variable generally results in sufficient power 
in logistic regression (Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996). For the three 
outcomes examined here, willingness to provide routine care had 171 “events”, willingness to 
initiate HT had 48, and willingness to continue HT had 116, allowing a maximum of 17, 4, and 
11 predictor variables in each of the three logistic regression models. Predictors were included 
in the multivariate analysis for each outcome if bivariate relationships with the outcomes were 
significant at the p<.10 level. For the model predicting willingness to initiate HT, an alpha level 
of p<.05 was used due to the need to limit the number of predictor variables to four variables 
in order to ensure that the event to predictor ratio was over 10.  
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CHAPTER 4: RESULTS 
The results of the study are described in this chapter, including the descriptive results, 
bivariate associations, and multivariate analyses (three logistic regression models).  
Descriptive Analyses 
Provider Characteristics 
Table 8 describes the primary care providers who participated in the study (N=223). In 
terms of socio-demographic characteristics, study participants were on average 41.3 years of 
age (SD=13.6). Over half of the respondents identified as female (59.5%) and White (56.1%). 
One-fifth (20.4%) identified as Asian or Pacific Islander, and 7.7% listed their race as African 
American or Black. Other participants described themselves as Southeast Asian or Asian Indian 
(6.7%), and less than 5% of participants were identified as Arab American/Middle Eastern, 
Hispanic, or other (data not shown). These categories were collapsed into an “other” category 
(15.8%). The majority of the sample identified as heterosexual (95.9%).  
In terms of religion, half of participants listed their religion as Christian (49.5%). Other 
frequently designated religious affiliations included Muslim (17.1%), Hindu (12.2%), and 
Agnostic or Atheist (8.1%). Most participants described themselves as either slightly, 
moderately, or very religious (80.3%). Other participants identified as not religious at all (19.7). 
About half of respondents indicated that they were politically liberal or very liberal (46.6%), 
about one third were moderate or “middle of the road” (36.3%), and 17.0% defined themselves 
as conservative or very conservative.  
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Table 8 
 
Provider Characteristics 
Variable N % 
   
Age (M, SD) 222 41.3 (13.6) 
   
Gender   
Male 90 40.5 
Female 132 59.5 
   
Race/ethnicity   
White 124 56.1 
African American/Black 17 7.7 
Asian or Pacific Islander 45 20.4 
Other 35 15.8 
   
Sexual Orientation   
Lesbian/Gay/Bisexual/Other 8 4.2 
Heterosexual  210 95.9 
   
Religion   
Agnostic/Atheist 18 8.1 
Christian 110 49.5 
Jewish 13 5.9 
Muslim 38 17.1 
Hindu 27 12.2 
Other 16 7.2 
   
Religiosity   
Not religious at all 44 19.7 
Slightly religious 48 21.5 
Moderate religious 105 47.1 
Very religious 26 11.7 
   
Political Views   
Liberal 104 46.6 
Moderate 81 36.3 
Conservative 38 17.0 
   
Specialty   
Internal Medicine/Family Medicine 163 73.1 
General Women’s Health (Ob/Gyn) 47 21.1 
Women’s Health Specialty 13 5.8 
   
Provider Type   
Resident 94 42.2 
Advanced Practitioner 23 10.3 
Attending Physician 106 47.5 
   
Note. N = 223. 
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Provider Type and Specialty 
Most respondents were either internal medicine or family medicine providers (73.1%) 
(Table 8). The rest of the participants were either general women’s health (ob/gyn) providers 
(21.1%) or women’s health specialty providers (5.8%) – for example, urogynecologists or 
reproductive endocrinologists. About half the sample was comprised of attending physicians 
(47.5%) and 42.2% of respondents were medical residents. The other 10.3% of respondents 
were advanced practitioners (physician assistants, nurse practitioners, or nurse midwives).  
Independent Variables 
Personal and clinical exposure to transgender individuals, empathetic attitudes, 
transphobia, barriers/facilitators, and willingness to treat transgender patients are described in 
Table 9. The results are discussed below.  
Exposure to Transgender Individuals 
Exposure to transgender individuals included two domains: personal exposure and 
clinical exposure. Most participants had previously met a transgender person (77.9%). 
Although only 4.1% of respondents had transgender family members or friends, 14.9% 
indicated that they had transgender acquaintances or colleagues. Approximately half of 
participants indicated that they had cared for a transgender patient in the past five years, but 
only 2.2% had ever initiated hormone therapy and 13.6% had ever continued a hormone therapy 
regimen initiated by another healthcare provider.  
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Table 9 
 
Personal and Clinical Exposure, Empathetic Attitudes, Transphobia, Self-efficacy, and 
Willingness to Care for Transgender Patients 
Variable n % 
   
Personal Exposure   
 Ever met a transgender person 173 77.9 
 Has transgender acquaintances or colleagues 33 14.9 
 Has transgender family or friends 9 4.1 
Clinical Exposure   
 Ever initiated hormone therapy regimen 5 2.2 
 Ever continued hormone therapy regimen 30 13.6 
 Cared for transgender patient in past 5 years 111 50.2 
Empathetic Attitudes Score (mean, SD) 214 5.8 (0.9) 
Transphobia Score (mean, SD) 201 3.1 (1.1) 
Self-efficacy   
 Don’t know how to bill for services 20 9.3 
 Lack of insurance reimbursement 7 3.3 
 Knowledge barriers scale (mean, SD) 211 1.9 (1.6) 
 Capable of providing routine care 138 62.4 
 Familiar with any hormone regimen (FTM or MTF) 28 12.7 
Willingness   
 Willingness to provide routine care 171 77.7 
 Willingness to initiate hormone therapy 48 22.1 
 Willingness to continue hormone therapy 116 53.2 
   
Note. N = 223. 
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Empathetic Attitudes 
Three empathy variables (measured on a 1-7 Likert scale, where 7 = “strongly agree”) 
were summed in order to create a scale. The mean for the summed items, “it is necessary for a 
healthcare provider to comprehend others’ experiences”, “I am able to value someone else’s 
point of view”, and “Considering a patient’s feelings is not necessary for patient-centered care” 
(reverse-coded) was 5.8 (SD = 0.9), indicating that on average, participants somewhat agreed 
or agreed with the empathy statements.  
Transphobia 
The mean transphobia score for participants was 3.1 (Range = 1-7; SD = 1.1). A score 
of 3 (somewhat disagree) indicates that on average, participants had moderately low levels of 
transphobia.  
Trangender Care-Related Self-efficacy 
The most frequently cited barriers to treating transgender patients were related to a lack 
of familiarity with transition care guidelines (57.0%), a lack of training in transgender-specific 
care (54.3%), a lack of exposure to transgender patients (38.1%), and a lack of knowledge about 
transgender patients among nursing or support staff (33.2%) (individual variables not shown). 
These items were used to construct a knowledge barriers scale - a count of the number of 
knowledge or exposure-related barriers that each participant faced (range = 0-4). The 
knowledge barriers scale mean was 1.9 (SD = 1.6) or nearly 2 knowledge barriers per 
participant (Table 9). Fewer participants indicated that they had administrative barriers, such as 
not knowing how to bill for transgender-specific services (9.3%) or that there is a lack of 
insurance reimbursement for transgender care (3.3%).  
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Fewer than two-thirds of providers (62.4%) reported feeling capable of providing 
routine care to transgender patients; only 12.7% were familiar with any gender transition 
hormone regimen (for either male-to-female transgender patients, female-to-male transgender 
patients, or both).  
Willingness to Provide Care 
Participants indicated whether they were willing to provide routine care, continue 
hormone therapy initiated by another provider, or initiate hormone therapy for transgender 
patients. The majority of participants agreed (strongly agreed, agreed, or somewhat agreed) that 
they were willing to provide routine care to male-to-female transgender patients (81.6%) as 
well as female-to-male transgender patients (81.2%) (data not shown). Most participants were 
willing to provide routine care to both FTM and MTF patients (77.7%). About half of survey 
respondents agreed (strongly agreed, agreed, or somewhat agreed) that they were willing to 
continue a hormone therapy regimen that was initiated by another healthcare provider (53.2%). 
Among survey respondents, 22.0% were willing to initiate a hormone therapy regimen for male-
to-female transgender patients and 22.9% were willing to initiate hormone therapy for female-
to-male patients (data not shown). About one-fifth (22.1%) of health providers surveyed were 
willing to initiate hormone therapy for both FTM and MTF patients.  
Bivariate Associations 
The following section describes the results of chi square tests and t-tests to test 
associations between independent variables and the study outcomes: willingness to provide 
routine care, willingness to continue a hormone therapy regimen, and willingness to initiate a 
hormone therapy regimen. The alpha level for bivariate associations was set at .10, which is 
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considered appropriate for studies with limited sample sizes and under circumstances where 
making a Type I error would not have severe consequences (Stevens, 2012). 
Factors Associated with Willingness to Provide Routine Care 
Provider type and specialty. Provider type and clinical specialty were associated with 
willingness to provide routine care, with internal medicine and family medicine providers more 
likely to be willing to provide routine care to transgender patients compared to general women’s 
health or specialty women’s health providers (85% vs. 63.8% and 76.9%, respectively). 
Medical residents (89.1%) were more likely than advanced practitioners to be willing to provide 
routine care (69.6 and 74.3%, p=.014).  
Provider characteristics. Age was associated with willingness to provide routine care; 
participants who were willing were younger on average (mean=40.2 years, SD = 13.7) 
compared to participants who were not willing to provide routine care (mean = 45.4 years, SD 
= 12.5) (Table 7). Political views were also associated with willingness to provide routine care, 
with more liberal participants being more likely to be willing (p=.088) (Table 5). However, 
gender, race, sexual orientation, religion, and religiosity were not associated with willingness 
to provide routine care to transgender patients. 
Exposure. Participants who had met a transgender person where more likely to 
indicate a willingness to provide routine care (84.2% vs. 66.7%, p=.007) (Table 6). In terms 
of clinical experience, providers who had cared for at least one transgender patient in the past 
five years were more likely to be willing to provide routine care to this population (p=.007). 
Transphobia and Empathetic Attitudes. Providers who were willing to provide 
routine care to transgender patients had higher empathy scores (mean = 5.9 vs. mean = 5.4) 
and lower transphobia scores (mean = 3.0 vs. mean = 3.5). 
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Self-efficacy. Those who reported that they felt capable of providing routine care to 
transgender patients (93.1% vs. 56.6%, p<.001) and reported fewer knowledge barriers (mean 
= 1.7 vs. mean = 2.5) were more willing to provide routine care to this population (Table 7). 
Those who reported that they did not know how to bill for services provided to transgender 
patients were less likely to be willing to provide routine care (60.0% vs. 81.9%, p=.020) 
(Table 6).  
Factors Associated with Willingness to Continue a Hormone Therapy Regimen 
Provider Type and Specialty. Residents were more likely to be willing to continue a 
hormone therapy regimen (63.0%) compared to advanced practitioners (47.8%) and attending 
physicians (45.6%, p=.045). There were no significant differences among specialties (Table 
5).  
Provider Characteristics. Provider characteristics that were associated with 
willingness to continue a hormone therapy regimen included race/ethnicity (p=.010) and 
religion (p=.021)(Table 5). White respondents (61.8%) and Jewish respondents (84.6%) were 
most willing. Gender, sexual orientation, religiosity, and political views were not associated 
with willingness to continue a hormone therapy regimen (Table 5).  
Exposure. Providers who had met a transgender person before were more likely to be 
willing to continue a hormone therapy regimen compared to those who had not (58.0% vs. 
35.4%, p=.006) (Table 6). Those who had initiated a hormone therapy regimen for a 
transgender patients in the past were also more likely to be willing to continue HT in the 
future (p=.034). Participants who had ever continued a hormone therapy regimen before were 
also more likely compared to participants who had not continued HT for a transgender patient 
in the past (79.3% vs. 49.2%, p=.010). In addition, those who cared for a transgender patient 
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in the past 5 years were more willing to continue a hormone therapy regimen as well 
(p=.076).  
Transphobia and Empathetic Attitudes. Both empathetic attitudes towards 
transgender patients and transphobia scale scores were significantly associated with 
providers’ willingness to continue a hormone therapy regimen (Table 8). Higher empathetic 
attitudes scores were found among participants who were willing to continue a hormone 
therapy regimen (mean=5.8, SD = 0.8) compared to those who were not willing (mean = 5.7, 
SD = 1.0, p=.095). Those who were willing had comparatively lower transphobia scores 
(mean = 2.9, SD = 1.0) compared to those who were not willing (mean = 3.3, SD = 1.1). 
 Self-efficacy. Those who reported being capable of providing routine care were more 
likely to be willing to continue hormones compared to those who did not agree that they were 
capable (58.5% vs. 43.9%, p=.036). Finally, providers who reported being familiar with a 
hormone therapy regimen for either FTM or MTF transgender patients were more likely to be 
willing (81.5% vs. 49.2%, p=.002).  
Factors Associated with Willingness to Initiate a Hormone Therapy Regimen 
Provider Type. Medical residents were more likely to be willing to initiate hormone 
therapy for transgender patients (35.9%) compared to advanced practitioners and attending 
physicians (p<.001), but there were no differences by specialty.  
Provider Characteristics. Two provider characteristics were associated with 
willingness to initiate a hormone therapy regimen: age and political views. Providers who 
were willing to initiate hormones were younger than those who were not (mean = 34.7 years, 
SD = 11.3 vs. mean = 43.1 years, SD = 13.7, p<.001)(see Table 9). Conservative or very 
conservative participants were less likely to be willing to initiate hormone therapy (8.3%) 
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compared to those who described themselves as moderate (26.3%) or liberal (23.8%) (Table 
6).  Gender, race, sexual orientation, religion, and religiosity were not associated with 
willingness to initiate HT. 
Exposure. Exposure variables were not significantly associated with willingness to 
initiate HT. 
Transphobia and Empathetic Attitudes. Transphobia and empathetic attitudes were 
not significantly associated with willingness to initiate HT. 
Self-efficacy. Participants who indicated that insurance reimbursement was a barrier 
were also more likely to be willing (57.1% vs. 21.2%, p=.025). Finally, those who reported 
being familiar with hormone regimens for FTM or MTF patients were more likely to be 
willing to initiate hormone therapy for these patients (37.0% vs. 20.0%, p=.046).  
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Table 10 
 
Chi Square Tests of Willingness to Provide Routine Care, Continue Hormone Therapy, and 
Initiate Hormone Therapy by Provider Characteristics 
Variable  
Routine 
Care 
% p  
Continue 
HT 
% p  
Initiate 
HT 
% p  
       
Gender  .815  .891  .578 
Male 80.7  54.0  24.1  
Female 79.4  53.1  20.9  
       
Race/ethnicity  .288  .010  .579 
White 77.7  61.8  18.9  
African American/Black 94.1  52.9  29.4  
Asian or Pacific Islander 75.6  32.6  27.3  
Other 80.0  48.5  21.9  
       
Sexual Orientation  .151  .567  .511 
Lesbian/Gay/Bisexual/Other 100.0  62.5  37.5  
Heterosexual  79.3  53.2  22.1  
       
Religion  .144  .021  .802 
Agnostic/Atheist 100.0  55.6  22.2  
Christian 80.7  57.9  19.8  
Jewish 61.5  84.6  15.4  
Muslim 75.7  47.2  27.8  
Hindu 77.8  29.6  18.5  
Other 87.5  43.8  31.3  
       
Religiosity  .143  .894  .496 
Not religious at all 90.7  56.8  27.9  
Slightly religious 68.8  51.1  23.4  
Moderately religious 78.6  53.9  21.6  
Very religious 73.1  48.0  12.0  
       
Political Views  .088  .459  .085 
Liberal 84.5  53.4  23.8  
Moderate 80.0  57.0  26.3  
Conservative 67.6  44.4  8.3  
       
Specialty  .006  .364  .355 
Internal/Family Medicine 85.0  50.3  20.1  
General Women’s Health  63.8  61.7  29.8  
Women’s Health Specialty 76.9  58.3  18.2  
       
Provider Type  .014  .045  <.001 
Resident 89.1  63.0  35.9  
Advanced Practitioner 69.6  47.8  17.4  
Attending Physician 74.3  45.6  10.8  
       
Note. N = 223. 
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Table 11 
 
Chi Square Tests of Willingness to Provide Routine Care, Continue Hormone Therapy, and 
Initiate Hormone Therapy by Exposure, Empathy, Transphobia/Subjective Norms, and Self-
Efficacy 
Variable 
Routine 
Care 
% p 
Cont. 
HT 
% p 
Initiate 
HT 
% p 
       
Personal Exposure 
Ever met a transperson  .007  .006  .567 
 Yes 84.2  58.0  23.1  
 No 66.7  35.4  19.1  
       
Transgender acquaintances or colleagues  .162  .164  .570 
 Yes 90.6  63.6  25.0  
 No 78.5  50.8  21.3  
       
Transgender family or friends  .131  .452  .135 
 Yes 77.8  66.7  50.0  
 No 80.5  52.4  21.2  
Clinical Exposure 
Ever initiated hormone therapy regimen  1.00  .034  .889 
 Yes 80.0  100.0  25.0  
 No 80.0  52.1  22.1  
       
Ever continued hormone therapy regimen  .777  .010  .461 
 Yes 80.0  79.3  27.6  
 No 79.8  49.2  21.0  
       
Cared for transgender patient in past 5 yrs  .007  .076  .263 
 Yes 85.5  59.3  25.0  
 No 70.4  47.2  18.7  
Self-efficacy 
Capable of providing routine care  <.001  .036  .485 
 Yes 94.1  58.5  23.3  
 No 56.6  43.9  19.3  
       
Familiar with any hormone regimen (FTM or MTF)  .887  .002  .046 
 Yes 78.6  81.5  37.0  
 No 77.4  49.2  20.0  
       
Don’t know how to bill for services  .020  .463  .401 
 Yes 60.0  45.0  30.0  
 No 81.9  53.6  21.8  
       
Lack of insurance reimbursement  .539  .827  .025 
 Yes 71.4  57.1  57.1  
 No 80.8  52.9  21.2  
       
Note. N = 223. 
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Table 12 
 
t-Tests of Association between Continuous Predictor Variables and Willingness to Provide 
Routine Care 
Variable 
Willingness to Provide Routine Care 
Yes 
M (SD) 
No 
M (SD) T df p 
      
Age 40.2 (13.7) 45.4 (12.5) -2.4 217 .018 
Empathy scale 5.9 (0.8) 5.4 (0.9) 3.3 210 .001 
Transphobia scale 3.0 (1.1) 3.5 (1.1) -3.1 197 .002 
Knowledge barriers scale 1.7 (1.6) 2.5 (1.6) -2.8 207 .005 
      
 
Table 13 
 
t-Tests of Association between Continuous Predictor Variables and Willingness to Continue 
Hormone Therapy 
Variable 
Willingness to Continue Hormone Therapy 
Yes 
M (SD) 
No 
M (SD) T df p 
      
Age 40.5 (14.0) 42.2 (13.2) -0.9 215 .377 
Empathy Scale 5.8 (0.8) 5.7 (1.0) 1.7 211 .095 
Transphobia Scale 2.9 (1.0) 3.3 (1.1) -3.0 198 .003 
Knowledge Barriers Scale 1.8 (1.6) 1.9 (1.6) -0.4 208 .722 
      
 
Table 14 
 
t-Tests of Association between Continuous Predictor Variables and Willingness to Initiate 
Hormone Therapy 
Variable 
Willingness to Initiate Hormone Therapy 
Yes 
M (SD) 
No 
M (SD) t df p 
      
Age 34.7 (11.3) 43.1 (13.7) -4.3 214 <.001 
Empathy Scale 5.8 (0.9) 5.7 (0.9) 0.5 210 .649 
Transphobia Scale 2.9 (1.1) 3.2 (1.1) -1.4 198 .159 
Knowledge Barriers Scale 1.7 (1.7) 1.9 (1.6) -0.9 207 .392 
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Multivariate Results 
Three binary logistic regression models were examined in order to simultaneously 
consider factors that predict willingness to provide routine care (Model 1), willingness to 
continue a hormone therapy regimen (Model 2), and willingness to initiate a hormone therapy 
regimen (Model 3). Control and predictor variables that were significantly associated with the 
outcomes in the bivariate analyses at the p<.10 level were included in the multivariate models, 
with the exception of Model 3, which used an alpha level of p<.05 in order to limit the number 
of predictor variables in the model due to sample size and power limitations (Peduzzi et al., 
1996). However, including only variables significant at the p<.05 level can fail to identify 
important associations (Bursac, Gauss, Williams, & Hosmer, 2008). In addition, the alpha level 
for reporting logistic regression results was set at .10 due to the relatively small sample size 
(Stevens, 2012). 
 
Model 1: Willingness to Provide Routine Care 
Variables entered into the logistic regression model to predict willingness to provide 
routine care included age, political views, provider specialty, provider type, ever met a 
transgender person, cared for transgender patients in the past 5 years, empathetic attitudes, 
transphobia, capable of providing routine care, billing barriers, and knowledge barriers (Table 
15). The overall model was significant, χ2(14, N=187) = 75.16, p<.001, Cox & Snell pseudo R2 
= .331.  
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Table 15 
 
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Provide 
Routine Care to Transgender Patients 
Variable AOR 95% CI p 
    
Age 0.99 0.94–1.04 .712 
    
Political Views    
Liberal (ref) 1.00   
Moderate 0.69 0.23–2.09 .507 
Conservative 0.73 0.17–3.22 .678 
    
Specialty    
Internal/Family Medicine (ref) 1.00   
General Ob/gyn 0.20 0.06–0.71 .013 
Specialty Ob/gyn 0.39 0.04–3.53 .400 
    
Provider Type    
Resident (ref) 1.00   
Advanced Practitioner 0.35 0.04–2.79 .320 
Attending Physician 0.18 0.04–0.81 .025 
    
Ever met transgender person 3.23 0.82–12.66 .093 
    
Transgender patients in past 5 years 1.04 0.32–3.39 .947 
    
Empathy 1.62 0.88–2.97 .121 
    
Transphobia 0.70 0.40–1.23 .213 
    
Capable of providing routine care to 
transgender patients 
13.22 4.45–39.31 <.001 
    
Billing barriers 0.48 0.09–2.46 .375 
    
Knowledge barrier scale 1.18 0.83–1.67 .363 
    
Note. N = 187. 
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Four variables significantly contributed to the model – provider specialty, provider type, 
ever met a transgender person, and capable of providing routine care. Compared to 
internal/family medicine physicians, general ob/gyn providers were less likely to be willing to 
provide routine care (AOR = 0.20, p=.013). Attending physicians were less likely to be willing 
to provider routine care to transgender patients compared to medical residents (AOR = 0.18, 
p=.025). Participants who had met a transgender person in the past were over three times more 
likely to be willing to provide routine care when other factors were controlled (AOR = 3.23, 
p=.093). Providers who reported that they felt capable of providing routine care were 13 times 
more likely to be willing to provide such care compared to others (AOR = 13.22, p<.001).  
Model 2: Willingness to Continue a Hormone Therapy Regimen 
The variables race, religion, provider type, ever met a transgender person, cared for 
transgender patients in the past 5 years, ever continued hormone therapy, transphobia, 
empathetic attitudes, capable of providing routine care, and familiar with any hormone therapy 
regimen were entered into a logistic regression model to predict willingness to continue a 
hormone therapy regimen initiated by another healthcare provider (Table 16). The model was 
significant, χ2(17, N=192) = 59.923, p<.001, Cox & Snell pseudo R2 = .268. 
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Table 16 
 
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Continue a 
Hormone Therapy Regimen Initiated by Another Provider 
Variable AOR 95% CI p 
    
Race    
Black (ref) 1.00   
Asian or Pacific Islander 0.55 0.10–2.86 .475 
White 1.13 0.29–4.37 .860 
Other 0.95 0.19–4.75 .950 
    
Religion    
Agnostic/Atheist (ref) 1.00   
Christian 3.25 0.89–11.86 .075 
Jewish 19.24 2.48–149.58 .005 
Muslim 1.86 0.38–9.06 .443 
Hindu 1.13 0.20–6.53 .892 
Other 1.25 0.24–6.92 .803 
    
Provider Type    
 Resident (ref) 1.00   
 Advanced Practitioner 0.19 0.55–0.66 .009 
 Attending Physician 0.26 0.12–0.58 .001 
    
Ever met transgender person 2.95 1.11–7.83 .030 
    
Transgender patients in past 5 years 0.62 0.27–1.41 .252 
    
Ever continued hormone therapy 5.06 1.49–17.24 .010 
    
Transphobia scale 0.71 0.48–1.05 .083 
    
Empathetic Attitudes 1.18 0.75–1.87 .470 
    
Capable of providing routine care to 
transgender patients 
1.80 0.87–3.72 .112 
    
Familiar with any hormone therapy 
regimen (for FTM or MTF) 
2.92 0.89–9.57 .077 
    
Note. N = 192. 
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Variables that significantly contributed to the model included religion, provider type, 
ever met a transgender person, ever continued hormone therapy, transphobia, and familiar with 
any hormone therapy regimen. Jewish providers were 19 times more likely to be willing to 
continue a hormone therapy regimen compared to agnostic or atheist providers (AOR = 19.24, 
p=.005), and Christian providers were also more likely (AOR = 3.25, p=.075). Advanced 
practitioners (AOR = 0.19, p=.009) and attending physicians (AOR = 0.26, p=.001) were less 
likely to be willing to continue hormones compared to residents. Those who had ever met a 
transgender person had greater odds of being willing to continue HT compared to those who 
had not (AOR = 2.95, p=.030). Participants who had ever continued a hormone therapy regimen 
for a transgender patient in the past were more likely to be willing to do so in the future (AOR 
= 5.06, p=.010), and those who were familiar with any HT regimen were also more willing 
(AOR = 2.92, p=.077). Finally, increased transphobia was associated with decreased likelihood 
of being willing to continue hormone therapy (AOR = 0.71 p=.083). 
Model 3: Willingness to Initiate a Hormone Therapy Regimen 
In the third logistic regression model, variables that had a significant bivariate 
association with willingness to initiate a hormone therapy regimen for transgender patients 
included age, provider type, familiar with any hormone regimen, and insurance barriers (Table 
17). The model was significant, χ2(5, N=209) = 30.021, p<.001, Cox & Snell pseudo R2 = .134. 
Three variables significantly contributed to the model: provider type, familiar with any 
hormone therapy regimen, and insurance barriers. Attending physicians had lower odds of being 
willing to initiate HT compared to residents (AOR = 0.31, p=.063). In addition, providers who 
were familiar with the hormone therapy regimen for FTM or MTF patients were nearly 3 times 
more likely to be willing to initiate this type of care compared to others (AOR=2.65, p=.059). 
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Finally, reporting insurance barriers increased the odds of being willing to treat transgender 
patients (AOR= 4.85, p=.089).  
Table 17 
 
Logistic Regression Analyses of Factors that Predict Providers’ Willingness to Initiate a 
Hormone Therapy Regimen for Transgender Patients 
Variable AOR 95% CI p 
    
Age 0.97 0.93–1.02 .271 
    
Provider Type    
Resident (ref) 1.00   
Advanced Practitioner 0.47 0.93–2.33 .353 
Attending Physician 0.31 0.09–1.07 .063 
    
Familiar with any hormone therapy regimen 
(for FTM or MTF) 
2.75 0.90–8.40 .075 
    
Barrier: Insurance 4.85 0.79–29.82 .089 
    
Note. N = 209. 
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CHAPTER 5: DISCUSSION 
This is the first study to assess primary care providers’ willingness to deliver both 
routine and transition care to transgender patients. The majority of providers surveyed in this 
study were willing to provide routine or basic care to transgender individuals; about half were 
willing to continue HT for transgender patients, and a minority (22%) were willing to initiate 
HT. This chapter discusses factors associated with willingness to provide each of these three 
types of care, the relationship of the findings to the Theory of Planned Behavior and Intergroup 
Contact Theory, implications for health care and social work, limitations, and directions for 
future research. 
Willingness to Provide Routine Care 
Routine care includes services such as chronic disease management, acute care for 
illnesses like influenza, pelvic examinations, and preventive care. Nearly one quarter of primary 
care providers surveyed were not willing to provide such basic care to transgender patients. 
This likely has a direct impact on access to care or perceived access to routine care this 
community. Although somewhat dated, one review found that only 30-40% of transgender 
individuals receive routine medical care (Feldman & Bockting, 2003). In contrast, 
approximately 80% of the general population reported having a regular source of care around 
the same time period (Beal, Doty, Hernandez, Shea, & Davis, 2007). 
Previously, Unger and colleagues found that among a sample of 
obstetrician/gynecologists from 9 different health systems, 88.7% were willing to perform 
routine pap smears for female-to-male patients and 80.4% were willing to perform breast 
examinations for male-to-female patients taking hormones or who had breast augmentation 
(2015). In this study, general women’s health providers and women’s health specialists were 
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willing to deliver routine care at lower rates of 63.8% and 76.9%, respectively. Although the 
difference in rates of willingness between this study and Unger’s study may be due to variation 
in measurement, the current study used incentives and had a somewhat higher response rate, 
possibly resulting in a more representative sample. Alternatively, providers in the Midwestern 
U.S. may be less willing to care for transgender patients compared to women’s health providers 
in other regions, as Unger’s study surveyed providers from multiple sites across the United 
States. 
Provider respondents who had met a transgender person before were over three times 
more likely to be willing to provide routine care to them. The relationship between personal 
exposure to transgender individuals and willingness to care for them has not been explored 
before. However, one previous study found that nursing students who had personal experience 
with lesbian, gay, or bisexual people were more comfortable providing care to LGB patients 
(Eliason & Raheim, 2000).  
Furthermore, there was a significant bivariate relationship between having cared for a 
transgender patient in the past 5 years and willingness to provide routine care for this 
population. Previous studies have similarly found associations between clinical exposure to 
LGBT patients and attitudes regarding, or comfort working with, LGBT patients (Baylor & 
McDaniel, 1996; Eliason & Raheim, 2000). However, clinical exposure variables did not make 
a significant contribution to the multivariate model predicting willingness to deliver routine 
care in this study.  
Finally, those participants who reported feeling capable of providing routine care to 
transgender patients were over 13 times more likely to be willing to provide such care. Previous 
qualitative studies have found that providers report feeling uncomfortable caring for 
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transgender patients due to a lack skills or training (Lurie, 2005; Poteat et al., 2013b). It may 
be that knowledge-related barriers explain the relationship between feelings of capability and 
willingness to deliver basic care to transgender patients. Post hoc analyses revealed that the 
relationship between knowledge-related barriers and feelings of capability was significant 
(participants who felt capable reported fewer barriers on average), but providers who report 
feeling capable did report a mean of 1.7 knowledge barriers. Therefore, knowledge does not 
completely explain the relationship between capability and willingness.  
Willingness to Continue Hormone Therapy 
Many transgender individuals are interested in pursuing hormone therapy as part of their 
transition process, and this simple step can have profound psychological benefits (Keo-Meier 
et al., 2015). Although endocrinologists are often part of an initial care team and initially 
prescribe hormone treatment, there is general agreement that primary care providers can 
continue HT and monitor its effects (Wilczynski & Emanuele, 2014), even among 
endocrinologists (Gardner & Safer, 2013). PCPs often initiate and monitor hormone therapy for 
a number of other purposes. However, only half of primary care providers surveyed in this study 
were willing to continue HT for participants who had been started on HT by another provider.  
Both personal and clinical factors contributed to providers’ willingness to continue HT. 
Similarly to routine care, those who had met a transgender person were more likely to be willing 
to continue HT. In addition, participants with lower levels of transphobia were more willing. 
These findings indicate that even when clinical experience is accounted for, personal values or 
attitudes still play a role in determining which providers are willing to assist transgender 
patients in transitioning to the gender with which they identify. Past studies have clearly 
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indicated that healthcare providers’ values and biases play a role in dictating their behavior and 
that physicians are often not even aware of their biases (Chapman, Kaatz, & Carnes, 2013).  
However, clinical specialty and experiences are also important; advanced practitioners 
and attending physicians were less willing to provide HT compared to medical residents. In 
addition, those who had participated in this kind of care before and those who reported being 
familiar with HT regimens for transitioning were more likely to be willing to continue HT for 
patients. Increasing familiarity with transition-related HT may be as simple as incorporating 
this topic into training programs; one recent study found that adding just a one-hour lecture on 
transgender health and hormone treatment significantly increased medical students’ comfort 
and willingness to treat transgender patients (Safer & Pearce, 2013).  
Willingness to Initiate Hormone Therapy 
Although endocrinologists have generally been tasked with initiating new HT regimens 
for transgender patients, initiating HT is considered straightforward and appropriate for primary 
care physicians to initiate as well (Gardner & Safer, 2013). Medical transition guidelines have 
evolved and are moving towards an informed consent model, where primary care physicians 
may be responsible for both identifying gender dyphoria issues and initiating a patient’s 
transition process (Wilczynski & Emanuele, 2014). Furthermore, access to transition care, 
particularly in non-urban areas where specialists may not be available, necessitates the 
involvement of primary care providers in initiating HT. However, very few respondents in this 
study (22%) were willing to initiate hormone therapy for transgender patients.  
Similarly to factors predicting willingness to continue HT, attending physicians were 
less likely to be willing to initiate HT compared to residents. Familiarity with HT regimens also 
increased the odds of willingness. However, those who reported insurance-related barriers to 
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treating transgender patients were nearly 5 times more willing to initiate HT. This may be 
because providers unwilling to deliver such care may not even realize that insurance-related 
barriers exist.  
Increasing primary care providers’ willingness to initiate and continue HT could greatly 
expand access to this service for a population that faces numerous barriers to transition care. 
For instance, improving access to HT through primary care may reduce unsafe behaviors such 
as self-medication with hormones procured through non-medical avenues (Xavier et al., 2013). 
Being able to access HT in primary care settings may have other benefits as well. Transgender 
patients who receive HT from endocrinologists may not access primary care, thus missing out 
on preventive care, cancer screenings, chronic disease management, and other important routine 
care services – including smoking cessation counseling and mental health screening. The 
benefits of receiving primary care have been well documented (Starfield, Shi, & Macinko, 
2005). If primary care physicians are willing to both initiate and continue HT, transgender 
patients will be more likely receive comprehensive health care services, which is particularly 
important given the health and mental health disparities that this population experiences 
(Coulter et al., 2015; Grant et al., 2010; Shires & Jaffee, 2015b). 
Furthermore, recent improvements in healthcare delivery include an increasing focus on 
establishing medical homes. Patients who have a medical home, by definition, have a regular 
doctor or provider, can reach their provider by phone, are able to get either healthcare services 
or medical advice in the evening or on the weekends, and have access to timely, organized care 
(Beal et al., 2007). Access to a medical home has been shown to decrease and almost eliminate 
racial disparities related to care access and quality (Beal et al., 2007). Access to a patient-
centered, culturally competent medical home may have similar benefits for other underserved 
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populations, including the transgender community. It may be that transgender individuals who 
are able to get transition care in a primary care setting may be more likely to seek out and 
continue to access a medical home. 
Theoretical Framework: Theory of Planned Behavior and Intergroup Contact Theory 
The hypotheses being tested in this study were that increased personal and clinical 
exposure, decreased transphobia, increased empathetic attitudes, and increased self-efficacy 
related to transgender patient care (fewer barriers and more facilitators) would increase the odds 
of being willing to provide routine care, continue HT, and initiate HT. Results indicate that 
personal exposure - specifically, having ever met a transgender person - increased the odds of 
being willing to provide both routine care and continue HT. In terms of clinical exposure, 
having provided care in general to transgender patients was not predictive, but ever having 
continued HT for a transgender patient increased the odds of being willing to do so in the future. 
This suggests that intergroup contact theory did add substantively add to the theoretical 
framework for the study, and potentially that personal contact is more salient than clinical 
contact. This may be explained by intergroup contact theory’s principle that having equal status 
among individuals is important in fostering positive interactions (Gierman-Riblon & Salloway, 
2013; Pettigrew, 1998). The unequal power dynamic between healthcare providers and their 
patients may be particularly relevant when it comes to transgender patients who are put in the 
position of having to educate their providers instead of the other way around (Poteat et al., 
2013a).  
According to the Theory of Planned Behavior, attitudes (in this study, empathetic 
attitudes towards transgender patients), subjective norms (transphobia), and perceived 
behavioral control (self-efficacy) should all contribute to behavioral intention (willingness). 
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Although empathy was associated with willingness to provide routine care and continue HT in 
the expected direction in the bivariate analyses (i.e., those who were willing to provide care had 
higher empathy scores), empathy was not a significant contributor to any of the multivariate 
models. Transphobia contributed significantly only to the model predicting willingness to 
continue HT, and in the expected direction – transphobia decreased the odds of willingness to 
continue HT. In the general population, negative attitudes towards transgender people are 
correlated with traditional ideas about gender and binary gender beliefs (Norton & Herek, 
2013). It may be that more transphobic providers may be willing to provide routine care to 
transgender patients, but not be willing to participate in the gender transition process due to 
their personal beliefs about gender.  
Self-efficacy proved to be important in each of the models: feeling capable of providing 
routine care significantly increased the odds of being willing to do so, and being familiar with 
any HT regimen increased the odds of being willing to both continue and initiate HT. Only one 
barrier was important to willingness, but not in the expected direction: providers who reported 
barriers around being able to procure insurance reimbursement for transgender health care were 
more likely to be willing to initiate HT. This may be accounted for by the feedback loops 
included in the Theory of Planned Behavior: the relationship between behavior/intention and 
behavioral control is often bidirectional (Ajzen, 1991). It may be that only providers who were 
interested in providing HT or had done so in the past were aware of potential barriers such as 
insurance reimbursement issues.  
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Study Implications 
Medical Education 
Improving transgender care-related self-efficacy, particularly feelings of capability and 
familiarity with hormone regimens, should begin with including transgender health content in 
both medical and nursing education curricula. A recent study found that the median time spent 
on LGBT health in medical school curricula in Canada and the U.S. was 5 hours total. However, 
only 30.3% of medical schools report spending any time at all on the topic of gender 
transitioning and 34.8% cover sex reassignment surgery (Obedin-Maliver et al., 2011). In 
addition, only 16% of allopathic medical schools in the United States provide what they identify 
as comprehensive LGBT training for faculty physicians who are teaching medical students and 
residents; over half provide no such training for faculty physicians (Khalili, Leung, & Diamant, 
2015). For the minority of programs that do provide faculty training, there is no information 
available on how much time or content is devoted specifically to gender identity issues or 
transgender health. 
There is evidence that simply adding transgender health topics to medical education and 
training can be effective. Although willingness to provide care was not assessed, one recent 
study found that delivering a single transgender health lecture as part of a family medicine 
clerkship for medical students resulted in increased knowledge, positive attitudes, and 
perceived skills for participants compared to students that did not receive the transgender health 
lecture (Dowshen, Nguyen, Gilbert, Feiler, & Margo, 2014). Another recent study found that 
adding just a one-hour lecture on transgender health and hormone treatment significantly 
increased medical students’ comfort and willingness to treat transgender patients (Safer & 
Pearce, 2013).  
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Given the relationship between personal contact with transgender individuals and 
willingness to provide care in this study, it may be even more beneficial to incorporate personal 
exposure into medical training. In fact, a recent intervention trial informed by intergroup contact 
theory found that a transgender speaker panel was significantly more effective in reducing 
transphobia than a traditional lecture about transgender-specific topics (Walch et al., 2012).  
Others have suggested that higher level changes could be effective in improving 
healthcare providers’ competency and knowledge around LGBT health, including adding 
questions about transgender health to national exams (such as the United States Medical 
Licensing Examination) or requiring transgender health-related training or other requirements 
as part of healthcare accreditation processes (Obedin-Maliver et al., 2011). This may begin to 
change norms around responsibility and capability for providing transgender care. With respect 
to women’s health care providers, Obedin-Maliver and colleagues explain, “Expanding our 
practices to provide for transgender individuals will not diminish our care of cisgender women, 
but rather will extend our services to others in need. Let’s make the pie bigger and apply our 
prior baking lessons; let’s bring our knowledge, skills, and passion for advocacy to a 
marginalized group while redefining ourselves as reproductive health physicians” (Obedin-
Maliver, 2015, p. 110). 
Social Work and Social Justice 
The transgender population is arguably one of the most marginalized groups in the 
United States, and social workers have an ethical obligation to reduce discrimination and 
oppression of vulnerable groups, including those marginalized due to their gender identity 
(National Association of Social Workers, 2008). Results of this study indicate that some 
providers are not willing to provide even routine or basic care to transgender individuals, and 
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many are not willing to continue HT, although this service is well within the purview of these 
medical specialties. Efforts should be made in both social work education and social work 
practice in order to advocate for transgender individuals seeking healthcare. 
Social work education. Social work education has long placed an emphasis on 
developing cultural competence among social work practitioners, first with an emphasis on 
racial and ethnic diversity and then expanding to focus on competence related to a number of 
minority or cultural groups – including sexual minorities. A number of studies have assessed 
the climate of social work education related to LGBT issues in general. One recent study found 
little evidence of negative attitudes towards LGBT people among a national sample of graduate 
social work faculty (Woodford, Brennan, Gutiérrez, & Luke, 2013), although negative attitudes 
were endorsed more frequently when the sample included non-graduate faculty and was limited 
to heterosexual respondents (Chonody, Woodford, Brennan, Newman, & Wang, 2014). Despite 
exposure to cultural competence training, social work students still report experiencing 
homophobia in social work classroom settings (Dentato et al., 2016) as well as conflict between 
religious social work students and lesbian, gay, and bisexual social work students (Joslin, 
Dessel, & Woodford, 2016).  
To date, there have been no published studies of social work student – or faculty - 
attitudes towards or experience with transgender clients or individuals specifically. 
Unpublished data indicate that MSW students in one Midwestern university have similar or 
greater levels of personal exposure to transgender individuals compared to the healthcare 
providers in this study; 12.9% of MSW students reported having transgender friends and 0.9% 
reported having transgender family members (Jaffee, Dessel, & Woodford, 2013). Further 
research is needed to determine the level of bias that social work students exhibit towards 
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gender minorities and how to mitigate such bias so that social workers can serve as advocates 
for this marginalized community.  
Social work practice. As case managers, therapists, and critical members of medical 
teams, social workers often serve an advocacy role, including working to make sure that patients 
receive needed medical, mental health, and support services, ensuring that patients receive fair 
treatment, and taking into account a patient’s environment and level of social support when 
providing services. The Patient Protection and Affordable Care Act’s (ACA) support of 
integrated care (i.e., settings or systems that combine primary care and mental health care in 
some way) has the potential to place more social workers in healthcare settings and ensure that 
social workers play an integral role on healthcare teams (Davis et al., 2015).  
However, despite increased integration among health professionals, physicians tend to 
communicate primarily with other physicians, leaving allied health professionals – including 
social workers – out of patient care decisions (Zwarenstein, Rice, Gotlib-Conn, Kenaszchuk, & 
Reeves, 2013). One method of increasing collaboration among social workers, physicians, and 
other healthcare providers is through the use of inter-professional education (IPE) or bringing 
together various disciplines for training purposes. IPE is common in social work education 
(Taylor, Coffey, & Kashner, 2015) but generally less valued by physicians and medical 
students/residents (Kashner et al., 2016). Because the social work profession has long 
championed IPE, social workers are in a unique position to advocate for this type of training 
(Taylor et al., 2015), and in particular, to address head-on power inequities between physicians 
and other professionals (Zwarenstein et al., 2013) that may limit collaboration and 
communication that may be beneficial for vulnerable patients such as transgender individuals.  
63 
 
In addition, social workers in private practice or other therapist roles who counsel 
transgender clients through gender transition should be aware that not all primary care providers 
are willing to initiate or even continue HT. Accordingly, social workers who are helping to 
guide transgender individuals through the medical transition process should develop a network 
of supportive providers, including those who are willing to provide routine care as well as HT. 
Healthcare Policy 
Legal protections for transgender Americans are generally lacking. Fewer than half of 
states in the U.S. prohibit employment discrimination on the basis of gender identity, and even 
fewer states prohibit housing discrimination based on gender identity (Human Rights 
Campaign, 2016). However, the ACA does prohibit healthcare discrimination based on gender 
identity, making it illegal for insurance companies to deny transgender patients coverage and 
for transgender patients to be denied care – particularly from providers or systems who receive 
federal (i.e., Medicaid or Medicare) funds (U.S. Department of Health and Human Services, 
2010).  
Provisions of the ACA may increase the proportion of transgender individuals who are 
insured and seek access to both routine and transition care. Although the legal landscape is 
changing for transgender patients, results of this study indicate that primary care providers’ 
training, experience, and personal values related to caring for transgender patients are lagging 
behind. Providers may be legally required to care for transgender patients but may be unwilling 
or feel incapable of doing so, particularly in the case of initiating or continuing hormone 
therapy. 
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Study Limitations 
This study is not without limitations. Study limitations related to the cross-sectional 
nature of the data, participant sample, sample size, and study instruments are described below. 
Cross-Sectional Study 
Causality cannot be established due to the cross-sectional nature of the data. However, 
this is the first study to establish significant associations between willingness to provide care to 
transgender individuals and both personal and clinical factors that may influence primary care 
providers.  
Participant Sample 
This sample may be biased towards providers who are more sympathetic to or interested 
in the transgender population or transgender health care. However, the use of incentives and 
resulting high response rate may have helped to mitigate non-response bias in this study 
(Massey & Tourangeau, 2013). Furthermore, healthcare providers may have over-reported their 
willingness to treat transgender patients due to social desirability. Others have found that 
physicians routinely overestimate their positive behaviors, such as adhering to medical 
guidelines (Adams, Soumerai, Lomas, & Ross-Degnan, 1999). In addition, data were collected 
in one Midwestern, urban/suburban health system. Results may not be generalizable to 
healthcare providers in less integrated health systems, other parts of the country, or rural areas, 
and further studies should assess unique factors that may impact other providers’ willingness 
to deliver various types of care to the transgender population.  
Sample Size 
The relatively small sample size precluded the inclusion of all variables of interest in 
the multivariate analyses. Larger and multisite studies are needed to not only replicate these 
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findings, but to have adequate power to include all variables of interest. A larger sample may 
lend itself not only to multi-level modeling to explore the influence of factors such as clinic 
environment, but also structural equation modeling in order to determine significant pathways 
between variables of interest and to more thoroughly test the theoretical model. 
Instrument 
With the exception of the empathetic attitudes and transphobia scales, questions used in 
this study were modified or created specifically for use in this study. The reason for this is the 
innovative nature of this work and dearth of literature and measures on which to draw. The 
general confirmation of the study’s theoretical framework through the use of these created 
measures lends some credence to the validity of the constructed measures. However, the 
validity and reliability of most questions was not assessed or tested, so future studies should 
seek to validate the new items and measures created and modified here. In addition, the 3-item 
empathetic attitudes scale exhibited low internal consistency. This scale was included used 
nonetheless due to the consistent association between the individual items and the outcome 
variables. 
Future Research 
The results of this study suggest a number of potential next steps. First, it is unclear 
what factors contribute to feelings of capability among providers. Future studies are needed, 
perhaps qualitative studies, to assess why some providers feel more capable of delivering 
routine care to transgender patients than others and how feelings of self-efficacy can best be 
cultivated. In particular, it would be important to assess various aspects of perceived capability, 
including not only medical knowledge but also perceptions of cultural competence and 
confidence that providers can interact appropriately and respectfully with transgender patients. 
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Furthermore, the focus of the survey and this study was a small segment of the 
transgender continuum. This study focused on male-to-female patients or female-to-male 
patients; i.e., those most likely to be interested in medical transition services such as hormone 
therapy. What is also critical to understand is how providers feel about caring for gender-queer 
and gender non-conforming patients, who may be subject to similar bias and discrimination but 
who may be more difficult for providers to both identify and understand. Gender non-
conforming or genderqueer individuals report avoiding or delaying medical care due to fear of 
discrimination at higher rates than transgender-identified individuals (Harrison, Grant, & 
Herman, 2012). Thus, it is critical to understand how providers perceive patients with diverse 
gender identities and what type of barriers they may face to providing care to gender non-
conforming patients who do not identify as transgender and who are not interested in medical 
transition care. 
Finally, although this study measured behavioral intentions, actual provider behavior 
was not measured. Although intentions are often highly correlated with behavior, they are 
generally far from perfectly correlated (Kim & Hunter, 1993). Future studies should 
systematically assess how often providers accept transgender patients versus referring them to 
other providers or simply refusing them both routine and transition care. 
Conclusions 
This is the first study to examine whether practicing primary care providers are willing 
to provide routine care and hormone therapy to transgender patients. Although most primary 
care physicians and other providers are willing to provide routine care to this patient population, 
far fewer are willing to provide HT, for a number of reasons which may include both clinical 
experience and personal reasons. Social workers can help transgender individuals navigate a 
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healthcare system where they may encounter providers who are not willing to treat them as well 
as advocate for better access to care for the transgender population.  
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APPENDIX: PROVIDER SURVEY 
 
Caring for Transgender Patients 
This survey is both confidential and voluntary. Results will only be reported in aggregate, and 
you can stop participating at any time. We are interested in your opinions about and experiences 
with transgender patients and their medical care.  
 
The following questions are about you. Please choose one answer unless otherwise indicated. 
 
How many years have you been in practice since completing your training?  
a) I’m a resident/fellow 
b) 0-4 
c) 5-9 
d) 10-14 
e) 15-19 
f) 20 or more 
 
1. What is your current age? ___ years  
 
2. Where did you attend high school? 
a) North America or the Caribbean 
b) Middle East 
c) Central or South America 
d) Asia 
e) Africa 
f) Europe 
g) Australasia 
 
3. Which of the following race/ethnicity groups best describes you (check all that apply): 
a) African American or Black 
b) Asian American / Pacific Islander 
c) Latina/o or Hispanic 
d) Native American or American Indian  
e) White or Caucasian 
f) Other _____________ 
 
4. What is your biological sex? 
a) Female 
b) Male 
c) Other: __________ 
 
5. Do you identify primarily as a: 
a) Woman 
b) Man 
c) Other: ______________ 
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6. Do you identify primarily as: 
d) Heterosexual  
e) Gay  
f) Lesbian 
g) Bisexual 
h) Other: ______________ 
 
7. What is your primary religious identity? 
a) Agnostic/Atheist 
b) Christian  
c) Jewish 
d) Muslim 
e) Hindu  
f) Other _____________ 
 
9. To what extent do you consider yourself a religious person? 
a) Very religious 
b) Moderately religious  
c) Slightly religious 
d) Not religious at all  
 
10. How would you describe your political views?  
a) Very liberal 
b) Liberal 
c) Moderate/middle of the road 
d) Conservative 
e) Very conservative 
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The next questions are about your personal and clinical experience with transgender 
individuals.  
 
Before answering the following questions, please consider these definitions: 
 
TERM DEFINITION 
Gender Identity A person's innate, deeply felt psychological identification as a man, 
woman or some other gender, which may or may not correspond to 
the sex assigned to them at birth 
Transgender Person An individual whose gender identity does not conform to what is 
typically associated with the legal and biological sex to which they 
were assigned at birth. 
Female-to-Male A person who was assigned female at birth but identifies as male 
Male-to-Female A person who was assigned male at birth but identifies as female 
 
11. About how many hours of formal education about transgender health have you had in a medical 
educational setting (i.e, medical school, nursing or PA school, residency, CME, CEU, etc.)?  
___ hours  
 
12. About how many hours of informal education (i.e., reading, self-directed learning, etc.) about 
transgender health have you had?  
___ hours 
 
13. Have you ever met a transgender person? Yes No 
14. Do you have any acquaintances or colleagues who are transgender? Yes No 
15. Do you have any close friends or family who are transgender? Yes No 
16. Have you ever newly prescribed hormone therapy for a transgender 
patient? 
Yes No 
17. Have you ever continued a hormone therapy regimen initiated by another 
provider for a transgender patient? 
Yes No 
18. Have you ever been involved in a patient’s transition process (e.g. 
referrals, lab monitoring, transition-related counseling, etc.)? 
Yes No 
 
19. In the past 5 years, how many transgender patients have you cared for?    
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Below you will find a list of statements. Next to each item, please indicate how much you agree 
with each statement, using the following scale.  
 
Routine Medical Care for Transgender Patients 
 
 Strongly 
disagree 
Disagree Somewhat 
disagree 
Neutral Somewhat 
agree 
Agree Strongly 
agree 
Not 
Applicable 
20. I am 
capable of 
providing 
routine 
medical care 
to transgender 
patients. 
1 2 3 4 5 6 7 8 
21. I am 
willing to 
provide 
routine 
medical care 
to male-to-
female 
transgender 
patients. 
1 2 3 4 5 6 7 8 
22. I am 
willing to 
provide 
routine 
medical care 
to female-to-
male 
transgender 
patients. 
1 2 3 4 5 6 7 8 
23. I am 
willing to 
perform PAP 
smears for 
female-to-
male patients. 
1 2 3 4 5 6 7 8 
24. I am 
willing to 
perform 
digital rectal 
exams for 
male-to-
female 
patients. 
1 2 3 4 5 6 7 8 
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Cross-Sex Hormone Therapy for Transgender Patients 
 
 Strongly 
disagree 
Disagree Somewhat 
disagree 
Neutral Somewhat 
agree 
Agree Strongly 
agree 
Not 
Applicable 
25. I am familiar 
with the hormonal 
regimens for 
female-to-male 
gender transition. 
1 2 3 4 5 6 7 8 
26. I am familiar 
with the hormonal 
regimens for 
male-to-female 
gender transition. 
1 2 3 4 5 6 7 8 
27. I would 
continue a gender 
transition 
hormone therapy 
regimen initiated 
by another 
provider. 
1 2 3 4 5 6 7 8 
28. I am willing to 
initiate hormone 
therapy for 
female-to-male 
patients.  
1 2 3 4 5 6 7 8 
29. I am willing to 
initiate hormone 
therapy for male 
to-female 
patients.  
1 2 3 4 5 6 7 8 
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Next to each item, please indicate your level of agreement with each statement, using the 
following scale.  
 
 Strongly 
disagree 
Disagree Somewhat 
disagree 
Neutral Somewhat 
agree 
Agree Strongly 
agree 
30. My colleagues 
discourage me from caring 
for transgender patients. 
1 2 3 4 5 6 7 
31. My administration 
discourages me from caring 
for transgender patients. 
1 2 3 4 5 6 7 
32. Not knowing how to bill 
for services for transgender 
people discourages me from 
taking care of transgender 
patients. 
1 2 3 4 5 6 7 
33. Lack of insurance 
reimbursement discourages 
me from taking care of 
transgender patients 
       
34. My lack of familiarity 
with guidelines for 
transition care for 
transgender patients 
discourages me from caring 
for transgender patients. 
1 2 3 4 5 6 7 
35. My lack of training in 
transgender-specific care 
discourages me from caring 
for transgender patients 
1 2 3 4 5 6 7 
36. My lack of exposure to 
transgender patients 
discourages me from 
accepting transgender 
patients. 
1 2 3 4 5 6 7 
37. Lack of knowledge 
about transgender patients 
among my office staff, 
medical assistants, and/or 
nursing staff discourages 
me from caring for 
transgender patients 
1 2 3 4 5 6 7 
38. My religious beliefs 
discourage me from caring 
for transgender patients. 
1 2 3 4 5 6 7 
 
39. If a transgender patient in need of specialty transition care presented to my care today, I would be 
able to provide an appropriate referral to a local: 
 
a) endocrinologist specializing in transgender care (Yes/No) 
b) surgeon specializing in transgender care (Yes/No) 
c) mental health provider specializing in transgender care (Yes/No) 
d) advocacy or social service agency for the transgender community (Yes/No) 
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The following questions pertain to your attitudes and feelings towards transgender patients. 
Please mark the number on the scale below that indicated your level of agreement or 
disagreement with each statement. 
 
 Strongly 
disagree 
Disagree Somewhat 
disagree 
Neutral Somewhat 
agree 
Agree Strongly 
agree 
40. It is necessary for a 
healthcare practitioner to be 
able to comprehend 
someone else’s experiences.  
1 2 3 4 5 6 7 
41. I will not allow myself 
to be influenced by 
someone’s feelings when 
determining the best 
treatment.  
1 2 3 4 5 6 7 
42. I am able to value 
someone else’s point of 
view. 
1 2 3 4 5 6 7 
43. Considering someone’s 
feelings is not necessary to 
provide patient-centered 
care.  
1 2 3 4 5 6 7 
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Below you will find a list of statements. Next to each item, please indicate your level of 
agreement with each statement, using the following scale.  
 
 
 Strongly 
disagree 
Disagree Somewhat 
disagree 
Neutral Somewhat 
agree 
Agree Strongly 
agree 
44. When I meet someone it 
is important for me to be 
able to identify them as a 
man or a woman. 
1 2 3 4 5 6 7 
45. I believe that the 
male/female dichotomy is 
natural. 
1 2 3 4 5 6 7 
46. I am uncomfortable 
around people who don’t 
conform to traditional gender 
roles, e.g., assertive women 
or emotional men. 
1 2 3 4 5 6 7 
47. I believe that a person 
can never change their 
gender. 
1 2 3 4 5 6 7 
48. A person’s genitalia 
define what gender they are, 
e.g., a penis defines a person 
as being a man, a vagina 
defines a person as being a 
woman. 
1 2 3 4 5 6 7 
49. I think there is something 
wrong with a person who 
says that they are neither a 
man nor a woman.  
1 2 3 4 5 6 7 
50. I would be upset if 
someone I’d known for a 
long time revealed to me that 
they used to be another 
gender. 
1 2 3 4 5 6 7 
51. I avoid people on the 
street whose gender is 
unclear to me. 
1 2 3 4 5 6 7 
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Please indicate whether you believe that the following statements are true or false.  
 
52. Transgender patients using cross-sex hormones should be monitored for endocrine changes every 3 
months in the first year and then once per year for the duration of hormone use. 
 
53. The best way to assess which pronoun to use (i.e., he or she) when addressing a transgender patient 
is to use the sex listed in their medical record. 
 
54. In most cases, Medicaid will pay for gender transition surgery (Gender Reassignment Surgery). 
 
55. The diagnostic criteria for Gender Dysphoria according to the World Professional Association for 
Transgender Health (WPATH) states that symptoms must be present for at least two years. 
 
56. Failure of treatment with SSRI/SNRIs is required prior to genital surgery. 
 
57. Mental health assessment is needed prior to genital surgery. 
 
58. In most cases, 12 months of hormone therapy is expected prior to genital surgery. 
 
59. Current guidelines for cross-sex hormone treatment for transgender patients are based on a number 
of randomized controlled trials (Level A evidence) . 
 
60. After mastectomy, female-to-male transgender individuals should continue being screened 
regularly for breast cancer. 
 
61. A transgender man is someone who was assigned female at birth but identifies as male. 
 
62. Transgender people are at increased risk for suicidal ideation. 
 
63. Transgender individuals are no more likely to be unemployed than the rest of the population. 
 
64. Completing this survey has increased my awareness of transgender people’s healthcare needs. 
 
Strongly agree Agree somewhat Neutral or 
undecided 
Disagree 
somewhat 
Strongly disagree 
 
65. I am interested in receiving further training about: 
transition care for transgender patients (Yes/No) 
issues in routine care of transgender patients (Yes/No) 
how to provide culturally sensitive care to transgender patients (Yes/No) 
 
66. Do you have any additional comments or thoughts about this survey or treating transgender 
patients that you would like to share with the research team? 
Thank you for completing this survey! 
 
77 
 
Please provide your name and address so that we can mail your gift card to you. This information will 
be stored separately from your survey answers and will not be used for any other purpose.  
 
Name:         
Mailing Address:           
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Transgender individuals report being denied healthcare services, but very little is known 
about primary care providers’ (PCP) willingness to deliver either routine or transition care to 
the transgender community. The purpose of this study is to examine PCP willingness to deliver 
routine care, continue a hormone therapy (HT) regimen initiated by another provider, and 
initiate HT for transgender patients using a theoretical framework informed by the Theory of 
Planned Behavior and Intergroup Contact Theory. The study sample was all family medicine, 
internal medicine, and women’s health providers in a large integrated Midwestern health 
system. Eligible participants were emailed a unique link to an online survey assessing clinical 
and personal exposure to transgender individuals, empathetic attitudes, transphobia, self-
efficacy, willingness to deliver care, and socio-demographics. While the majority of providers 
were willing to provide routine care to transgender patients, only half (53%) were willing to 
continue HT and even fewer (22%) were willing to initiate HT. Factors that increased the odds 
of willingness to provide routine care included personal exposure to transgender individuals 
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and feelings of capability. Being Christian or Jewish, personal and clinical exposure to 
transgender individuals, decreased transphobia, and familiarity with HT regimens increased the 
odds of willingness to continue HT. Familiarity with HT and reporting insurance barriers 
increased the odds of willingness to initiate HT. Both cultural and policy shifts and provisions 
of the ACA will increase access to care for transgender patients; in order for healthcare systems 
to adapt, both medical education and social work education should address cultural competence 
issues around transgender care.  
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